Wilfrid Laurier University

Scholars Commons @ Laurier
Theses and Dissertations (Comprehensive)
2019

Functional Characterization of O-Acetyltransferase WssI: Role in
Bacterial Cellulose Acetylation of Achromobacter insuavis and
Pseudomonas fluorescens
Alysha Burnett
burn2000@mylaurier.ca

Follow this and additional works at: https://scholars.wlu.ca/etd
Part of the Biochemistry Commons, Integrative Biology Commons, and the Molecular Biology
Commons

Recommended Citation
Burnett, Alysha, "Functional Characterization of O-Acetyltransferase WssI: Role in Bacterial Cellulose
Acetylation of Achromobacter insuavis and Pseudomonas fluorescens" (2019). Theses and Dissertations
(Comprehensive). 2136.
https://scholars.wlu.ca/etd/2136

This Thesis is brought to you for free and open access by Scholars Commons @ Laurier. It has been accepted for
inclusion in Theses and Dissertations (Comprehensive) by an authorized administrator of Scholars Commons @
Laurier. For more information, please contact scholarscommons@wlu.ca.

Functional Characterization of O-Acetyltransferase WssI: Role in Bacterial Cellulose
Acetylation of Achromobacter insuavis and Pseudomonas fluorescens

By
Alysha Burnett

Thesis Submitted to the Department of Biology, Faculty of Science
In Partial Fulfillment of the Master of Science Degree in Integrative Biology
Wilfrid Laurier University, 2019

(Alysha Burnett) 2019Ó

Dedication

This thesis is dedicated to my parents, Bill and Deanna. Thank you for providing me with the
opportunity to peruse my undergrad and graduate education. Your endless support and
encouragement will never go unnoticed.

.

1

Acknowledgements
I would like to recognize my supervisor Dr. Joel Weadge for providing me with many valuable
opportunities throughout my master’s degree. Thank you for dedicating so much of your time
and patience to help me excel as a scientist. Your encouragement and guidance were greatly
valued.
Thank you to my committee members, Dr. Anthony Clarke and Dr. Matthew Smith for your
academic advice and support during my thesis.
Thank you to the Weadge, Suits and Horsman lab members in addition to Sidney Nechacov and
Chris Bartlett for the emotional support, scientific advice and overall positive moral they all
offered throughout my degree.
I would like to acknowledge Weadge lab members (specifically Rebecca Fievoli, Monica
Garner, and Cody Reese) who helped in the protein expression endeavor, helping produce over
200L of culture for HTS. Another special thank you to Adam Deruchie-Tan for his hard work on
the HTS inhibitor assays and IC50 curves, as well as Alex Anderson for his expertise with
bioinformatics.
I would like to acknowledge The Canadian Glycomics Network (GlycoNet) and the Ontario
Graduate Scholarship for providing funding for myself and this research project.

Lastly, to all of my family members, my friends and my boyfriend Tylor,
your interest, patience and praise were greatly appreciated.

2

Abstract
Cellulose biofilms consist of a community of bacterial cells encased in a self-produced
matrix of polymers (e.g. exopolysaccharides, such as cellulose) that facilitate a firm adherence to
surfaces. The acetylation (addition of an acetyl group on carbohydrates) is crucial in virulence;
thereby in some cases allowing opportunistic bacteria to cause harmful diseases. Pertaining to
this research, the wrinkly spreader (WS) genotype of Pseudomonas fluorescens colonizes the airliquid interface on food, water sources and human tissue to form a robust biofilm with the ability
to spread across surfaces. The composition of this biofilm largely consists of bacterial cellulose
polymers produced and acetylated by the proteins encoded by the wss operon. Specific mutations
of the wssFGHI genes result in the production of a non-acetylated cellulose-containing biofilm
variant, which is not as adherent to surfaces. This is important as other pathogenic bacteria also
contain the wss acetylation operon, such as the emergent human pathogen Achromobacter
insuavis. In relation to the proposed project, the pathogens P. fluorescens and A. insuavis contain
the wssI gene that is proposed to encode for an O-acetyltransferase protein, WssI. The purpose of
this research was to characterize WssI from both pathogens, to understand its role in the
production of acetylated cellulose and investigate its predicted role as an O-acetyltransferase
protein. All research objectives were achieved including optimizing the purification of WssI, and
functionally characterizing the esterase activity, optimal pH, and kinetic parameters. While
acetyltransfer could not be confidently detected under conditions tested in activity assays, WssI
did exhibit weak binding affinity of avicel initially detected in pulldown assays and low levels of
acetyltransfer were further verified by mass spectrometry with pNP-Ac and acetyl-CoA as
donors. In order to extrapolate information about the mechanism of action, the conserved active
site residues were studied in a series of experiments. Consistent with other close homologs of
published acetyltransferases, typical serine protease/esterase inhibitors did not lead to significant
reductions in activity; however, site directed mutagenesis of the genes encoding two of the
predicted catalytic triad residues (Ser and His) resulted in up to 50% inhibition of activity
dependent upon acetyl donor. Lastly, WssI was tested against potential enzyme inhibitors by
High Throughput Screening (HTS) assays. A small subset of the finalized list of 12 compounds
successfully inhibited WssI in the micromolar range, one of which is a commercial tyrosine
kinase inhibitor, implying that blockage of the ester cleavage may inhibit the overall activity of
WssI. The findings of this study outline the functional properties of WssI, which have never been
studied in vitro from any group in the literature. This thesis therefore contributes novel
information in regard to the Wss system for the purpose of advancing biofilm research for further
development of anti-acetylation or anti-biofilm agents in vivo.
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1. Introduction
1.1. Bacterial Biofilms
The National Institute of Health stated in 2002 that 80% of human bacterial infections
were biofilm associated1,2. These biofilm-forming microorganisms can be found in dental caries
causing periodontal disease, within chronic wound infections, urinary tract infections, as well as
within the airway mucosae of Cystic Fibrosis (CF) patients3. The strong adherence of these
bacteria also provide opportunity to thrive and colonize on the surface of medical devices, such
as catheters, stents, contact lenses and implantable electronic devices3,4. These persistent biofilm
infections are also elevated in resistance to traditional antimicrobial mechanisms (See Section
1.2.) adapting to stress conditions (i.e., bleach, up to 80% ethanol and heat), making the
treatment strategies a subject of concern for human health and antimicrobial resistance5.
Biofilms can also be found on fresh produce, such as sprouts, lettuce, melons, tomatoes
and spinach6. Plants were originally considered not to support the colonization and persistence of
pathogenic bacteria, but Escherichia coli and Salmonella enterica thrive within a biofilm,
acclimatizing to harsh environmental conditions on plants that other pathogens would not
withstand6. The prevalence and accumulated abundance of these pathogens contaminate the fresh
produce and can lead to foodborne outbreaks. The pathogens survive without causing disease
symptoms in planta but can colonize within animals6. Consumption of contaminated food and
water then allows the pathogenic bacteria to infect a new host, which can be excreted back into
the environment through animal feces6. Biofilm formation can be minimized or prevented by
reducing nutrients in the water, controlling temperatures and sanitizing typical growth sites7.
However, the chemical sanitation protocols used by industries, such as the use of chlorine
(bleach), other halogens and broad antimicrobial solutions are failing to reduce the attachment of
these pathogens on produce due to antibiotic resistance genes and persistent biofilm effects 6,7.
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Therefore, resistant and emergent plant pathogens are contributing to the spread of biofilms on
produce due to their ability to thrive and out compete other bacterial species that are not resistant
to such sanitization protocols6. The persistence of these pathogenetic bacteria leads to health
implications from human and plant pathogenic biofilms, followed by economical loss due to
healthcare costs, and food waste, thereby harming national economies, tourism and trade5.
By definition, bacterial biofilms are communities of bacterial cells encased in a matrix of
exopolysaccharides exported by constituent cells of the community. Biofilms can be produced by
both Gram-negative and Gram-positive bacteria, such as E. coli, Salmonella spp., Pseudomonas
spp., Achromobacter spp., (Gram-negative) and Bacillus spp., Staphylococcus spp., (Grampositive)1,8. In some biofilms, only one microbial species is prominent, while others contain a
polymicrobial biofilm. The formation of a biofilm by bacterial species is a mechanism of defence
to protect the cells from a variety of environmental stresses, including pH fluctuations, UV
radiation and osmotic shock7. In order for the bacterial species to persist and continue to
replicate, growing the biofilm, the exopolysaccharide matrix (Figure 1) protects cells against
such environmental factors. The protection allows species to thrive against specific antibody
production and thereby recognition by the immune host, in addition to other immune responses
such as antimicrobial peptides, enzyme degradation and reactive oxygen species8. Biofilms
facilitate strong adherence to a variety of surfaces, such as human tissue, medical devices, fresh
produce, and water sources; thereby further enhancing survival in unconventional conditions,
utilizing the matrix for protection7–9. The attachment of biofilms onto these surfaces present
opportunities for some bacterial species to become virulent, allowing subsequent infectivity of a
variety of hosts.
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Planktonic bacterial cells

Mature biofilm

Attachment

Cell division

Figure 1: Development Cycle of Biofilm Formation.
Biofilm formation begins with planktonic bacteria (a) reversibly and irreversible attaching to a
surface (b/c). Microcolonies form via cell division forming an extracellular matrix (d). A threedimensional mature biofilm structure may disintegrate from planktonic cells disassociating from
the matrix (f) or mechanical disruption causing a portion of the biofilm to shed (g). Figure
adapted from Römling and Balsalobre, 2012.
Biofilms also have an important role in evolution and genetic diversity in a microbial
community. Horizontal gene transfer allows new genetic traits to be introduced into the
community7. For example, mobile genetic elements, such as conjugate plasmids, transposons or
bacteriophages mediate horizontal gene transfer between bacterial cells7. The close proximity of
cells within the biofilm allow the transfer of genes to occur with minimal interruption, giving rise
to new phenotypic characteristics that allows bacterial communities to evolve, while promoting
the spread of antibiotic resistance through the new population7.

1.2. Biofilm Formation
Biofilms were experimentally detected as early as 1708 by Antonie van Leeuwenhoek,
who observed the biofilm of dental plaque using the earliest form of the microscope10,11. Since
then, significant advances have been made to understand the mechanism by which a biofilm
adheres, forms and persists. An overview of this mechanism is presented in Figure 1. The
development of a biofilm begins with planktonic (motile) bacteria (Figure 1a) reversibly and
then irreversibly attach to a conditioned surface (Figure 1b/c) 1. The formation of microcolonies
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(Figure 1d) occurs through cell division, while forming an extracellular matrix containing
proteins, exopolysaccharides (e.g., cellulose, poly-1-6-N-acetyl-glucosamine (PNAG), alginate,
etc.), and extracellular DNA1. This matrix contains a plethora of content that has been exported
from the bacterial cells that forms a well-coated, thick film visible on surfaces. The threedimensional mature biofilm can disintegrate allowing planktonic cells to disassociate (Figure 1f)
or be shed from the matrix by mechanical disruption permitting the biofilm to spread across the
surface, or to colonize in a new niche1.
A mature biofilm has increased chemical and antibiotic resistance (compared to
planktonic cells) through various mechanisms dependant on the organism within the biofilm and
the type of antibiotic treatment1. The resistance mechanisms include a decrease in growth rate
accompanied by an altered metabolism, with potential for accumulation of persister cells, which
vary from the wildtype cells within the biofilm1. While dormant, persister cells adapt to a slow
growth and metabolic rate in the presence of antibiotics, permitting these cells to be highly drug
tolerant due their ability to shift toxin-antitoxin (TA) balance 1,12. Persister cells are exposed to
the TA system from horizontal gene transfer, providing the cells with genes encoding harmful
toxins, and protective antitoxins allowing the persister cells within the biofilm to tolerate the
antibiotic5,12. In addition, the last antibiotic resistance mechanism, which biofilms can adapt to,
involves the increased fitness of the pathogenic bacteria within the biofilm that can thrive within
the presence of an oxygen gradient, which counteracts the mechanism of action of antibiotics
(e.g., 𝛽-lactamase resistance from decreased expression and/or affinity of antibiotics to penicillin
binding proteins involved in cell wall synthesis)1,13. These mechanisms of immune defence vary
for individual biofilms, as each is comprised of diverse microbial communities producing unique
extracellular matrices containing of a high abundance of various exopolysaccharides.
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1.3. Importance of Cellulose
In regard to this project, cellulose is the exopolysaccharide of interest that is exported by
bacterial cells, which makes up the major component of the biofilm. Cellulose is a polymer of β(1→4)-D-glucose units and is the most abundant biopolymer on earth9,14. The most common
forms of cellulose can be found in nature as a structural component of the plant cell wall, a major
component of cotton and wood14. Hemicellulose, the second most abundant polysaccharide in
nature is a relative of cellulose found in the plant cell wall15. This mixture of polymers
containing xylan is branched, and a heteropolymer containing pentose units (i.e., xylose and
arabinose) and hexaoses (i.e., mannose, glucose and galactose)15. Natural and derivatized
cellulose have been adapted for a variety of applications, such as a strengthening agent in paper
production, fibers used for clothing, advanced cosmetic formulations to increase viscosity and
skin hydration by bacterial cellulose masks, in addition to uses in pharmaceutical industries16–18.
Pharmaceutical companies vary the polymer for drug delivery systems for dose-controlled
release, adhesive treatments, and in other thickening, stabilizing and gelling agents for drug
formulation16. The vast diversity of modified cellulose applications emphasizes the importance
for further research of how this polymer is produced. Many of these applications utilize extracted
cellulose in its purest form from natural sources, such as plants and bacteria. Cellulose can be
synthesized by various widely distributed bacterial species such as Burkholderia spp. and
Pseudomonas putida (soil), plant pathogens Dickeya dadantii, Erwinia chrysanthemi and tumorproducing plant pathogen Agrobacterium tumefaciens14. As previously mentioned, E. coli and S.
enterica produce cellulose biofilms and have served as good model organisms for understanding
the synthesis of the polymer6,14. Each microbial biofilm contains diverse polysaccharide variants
that are produced by countless bacterial species with operons encoding proteins for biofilm
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production. Of relevance to this study, three Gram-negative operon systems were closely
analyzed due to protein homology and comparable synthesis pathways.

1.4. Exopolysaccharide Synthase Dependent Pathways
Gram-negative bacteria all share similar exopolysaccharide synthase dependent
pathways, such as the phosphoethanolamine (pEtN) modified cellulose, acetylated cellulose and
alginate systems (Figure 2). The operons of genes encoding proteins in all of the synthase
dependent pathways in Figure 3 outline the complexity of the gene organization of each
exopolysaccharide system, while highlighting important genes and their associated protein
functions present throughout each pathway.

Figure 2: Schematic Representation of Phosphoethanolamine Modified Cellulose, Acetylated
Cellulose and Alginate Exopolysaccharide Synthase Dependent Systems.
Cellulose polymer represented by blue circles (glucose) and alginate represented by green-top
and orange-top diamonds (mannuronic acid and guluronic acid). The protein colour codes
represent: synthase proteins (light green), c-di-GMP binding site (dark green), TPR-containing
protein (light yellow), 𝛽-barrel porin (yellow), exopolysaccharide modifying enzymes (pink),
synthase accessory protein (purple). Blue squiggly line represents the N-terminal lipid anchor of
AlgK. Figure updated and recreated from Whitney and Howell, 2013.
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Figure 3: Exopolysaccharide Synthase Dependent Loci of Gram-negative Bacteria.
The figure key outlines the confirmed or hypothesized function of the proteins encoded by the
genes listed. Abbreviations: P. aeruginosa, Pseudomonas aeruginosa; P. fluorescens.
Pseudomonas fluorescens; P. putida, Pseudomonas putida; P. syringae, Pseudomonas syringae;
A. vinelandii, Azotobacter vinelandii (alginate and acetylated cellulose); E. coli, Escherichia
coli; S. enterica, Salmonella enterica; V. fischeri, Vibrio fischeri; B. cenocepacia, Burkholderia
cenocepacia; G. xylinus, Gluconacetobacter xylinus (cellulose)9. Figure from Whitney and
Howell, 2013.
The proteins involved in the cellulose synthase dependent pathway originate from a set of genes
within the bacterial cellulose synthase (bcs) operon, also termed the wss operon in some
bacteria19–22. Synthesis of the cellulose polymer begins with the activation of BcsA by binding
cyclic-di-guanosine monophosphate (c-di-GMP) followed by the polymerization of UDPglucose9,14 -23. Specifically the secondary messenger c-di-GMP binds to the PilZ domain of BcsA
and allosterically activates cellulose synthesis23-24. BcsQ, homologous to the E. coli protein
MinD involved in cell division, is hypothesized to be required for localization of the apparatus to
the cell poles of E. coli, S. enterica, and Burkholderia cenocepacia9,14. BcsB contains a
transmembrane helix that anchors the protein to the membrane, allowing BcsB to assist BcsA in
guiding the polymerized cellulose into the periplasm with its two carbohydrate binding
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domains25,26. Recent studies by Cegelski and colleagues identified that the Bcs system exports
phosphoethanolamine (pEtN) modified cellulose polymer, as opposed to the originally predicted
unmodified cellulose27. Verification of modified polymer by solid state NMR in addition to gene
knockout studies combined with downstream biofilm physiological analysis. The knock out
studies identified that this modification is required for the formation of fibers and fibrils that
generate the cohesive and elastic integrity of the biofilm27. The pEtN modification is predicted to
produce resistance to cellulases in certain environments, due altered phenotypic effects from the
formation of long cellulose fibrils and amyloid curli fibers, which generate the protective
biofilm27. In addition, the formation of such curli fibers prevent hyper-stimulating immune
responses, which improve the overall fitness of the host27. Further mutation studies of the gene
for BcsG revealed that the pEtN modification on the C6 hydroxyl was absent; thereby suggesting
that BcsG is indispensable for this cellulose modification and that it is a phosphoethanolamine
transferase protein27. Following modification, the export of the modified cellulose polymer is
predicted to be facilitated by the outer membrane protein BcsC. This protein contains an Nterminal tetratripeptide repeat (TPR) domain within the periplasm, with a C-terminal porin
region, hypothesized to be involved in export of the polymer9,14,25. Lastly, BcsZ encodes for an
endo-β-1,4- glucanase, predicted to be located in the periplasmic space that facilitates cleavage
of accumulated cellulose in conjunction with possible release of the polymer from the cell
surface to allow formation of the capsule-like biofilm9,14,19,25.
Alginates are known to be synthesized by brown seaweeds and bacteria from the
Pseudomonas and Aztobacter genera28. The alginate from these genera exhibit different
structural features, with Pseudomonas contributing to the structure of a biofilm matrix.
Pseudomonas aeruginosa is known as an opportunistic human pathogen, where alginate is an
important factor for the virulence of this organism in the lungs of Cystic Fibrosis (CF)
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patients28,29. The overproduction of alginate from P. aeuruginosa interferes with host immune
defenses and antibiotic therapy, thereby allowing the pathogen to persist27. The alginate secretion
system from P. aeruginosa has been studied due to its clinical status, and originates through the
characterization of the proteins from the algD operon9.
The alginate biosynthetic complex is the most characterized exopolysaccharide secretion
system in the synthase-dependent category (Figure 2). Understanding the location and
mechanism of the alginate proteins is an important tool relevant to this project when inferring the
roles of homologous proteins involved in the cellulose complex, which are still being
characterized. Alginate is composed of varying amounts of (1-4)-linked β-D-mannuronic acid and
α-L-guluronic acid starting with Alg8 and Alg44 catalytically converting GDP-mannuronic acid
into poly (1-4)-β-D-mannuronic acid. These two work together to function like BcsA in the
cellulose pathway. Alg8 is the putative alginate synthase that catalyzes the polymerization of the
exopolysaccharide initiated by the binding activity of c-di-GMP with Alg4424,30,31. Similar to
BcsA/B, Alg44 is predicted to have an N-terminal c-di-GMP binding PilZ domain to activate the
polymerization and export of poly (1-4)-β-D-mannuronic acid across the membrane (Figure
2)24,32. The binding activity of c-di-GMP has been proven to regulate the polymerization and
export mechanism through site-specific mutations that hindered the production of alginate in
vivo9,32. The poly (1-4)-β-D-mannuronic acid is epimerized by the mannuronan C5 epimerase,
AlgG, in the periplasm complex32. AlgL is a periplasmic lyase that is predicted to be involved in
the degradation of misguided and unprotected alginate, as well as release of the growing polymer
from the cell28. AlgK is proposed to guide a mature alginate polymer towards the outer
membrane protein AlgE and mediate transport of alginate outside of the cell (similar to BcsC),
while holding the protein-carbohydrate complex together9,32. Lastly, the inner membraneanchored proteins AlgI and AlgJ along with the soluble periplasmic protein AlgF, are all
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involved in the O-acetylation of mannuronic acid units of the alginate polymer32,33. The high
amino acid sequence similarity of AlgJ and periplasmic protein AlgX is consistent with AlgX’s
role of also being involved in alginate acetylation, but this protein has a separate and distinct role
in O-acetylation compared to AlgJ, which displays esterase activity and does not bind to
polymers34,35. O-Acetylated alginate product is an important structural component of biofilms
that are formed by mucoid strains of P. aeruginosa, where it has been implicated as necessary for
strong surface attachment, increased polymer viscosity, reduced activation of phagocytosis and
reduced susceptibility to enzyme degradation in CF infections8. The chemical modification of Oacetylation on alginate has also been observed for cellulose biofilms. Similar implications are
discussed in Section 1.5. with respect to acetylated cellulose biofilm synthesis.

1.5. Acetylated Cellulose Biofilms
The O-acetylation of alginate is not unique since other exopolysaccharides, like microbial
cellulose, have more recently been discovered to also possess this chemical modification. The
acetylated cellulose pathway was originally identified by Dr. Andrew Spiers and colleagues
when experimental evolution studies were performed involving the plant-colonizing bacterium
Pseudomonas fluorescens SBW2536. The findings concluded that this bacterium underwent
divergent evolution through adaptation to a new niche; thereby causing development of a mutant
with a new phenotype that has a significant fitness advantage over the ancestral strain36,20. This
new mutant of P. fluorescens produces an acetylated cellulose biofilm that increases the fitness
of the microbes, enhances the spreading of the biofilm and improves the adherence to surfaces,
which together increase the virulence of this opportunistic species20,21,36.
The newly adapted cellulose-acetylating phenotype could be readily identified through its
unique colony morphology on solid agar, referred to as “Wrinkly Spreader” (Figure 4-Left). The
robust wrinkly spreader biofilm, also forms at the air-liquid interface (Figure 4-Right), shown as
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a thick layer on the surface of the growth media22. In subsequent work, Spiers and colleagues
were able to elucidate genes associated with the wrinkly spreader phenotype through transposon
mutagenesis20,21. A synthase dependent pathway, termed the wss operon (Figure 5), was found to
be responsible for both the synthesis and acetylation of cellulose containing biofilms. This
operon encodes for 10 proteins (wssA and wssJ not shown), which are homologous to genes
within the cellulose pathway (bcsABZC) and the alginate pathway (algXFIJ) (noted in Figure 5
and 6)9,20,22,36. Research involving the acetylated cellulose pathway is not as advanced in the
literature compared to the phosphoethanolamine modified cellulose and alginate biosynthetic
systems and therefore represent a significant gap in our understanding.

Figure 4: Acetylated Cellulose Biofilm Phenotype.
(Left) Wrinkly spreader colony morphology of P. fluorescens grown on LB containing Congo
Red agar. (Right) Wrinkly spreader phenotype of P. fluorescens biofilm formed at the air-liquid
interface in King Broth incubated for 3-7 d at 28 ℃22. Figure rendered from Spiers, et al. 2003.
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Gene Homologs bcsA
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Figure 5: wss Operon Encoding Proteins Within the Acetylated Cellulose Synthase Dependent
Pathway.
Genes represented in blue encode for proteins responsible for synthesis. These proteins are
homologous to synthesis proteins from the bacterial cellulose synthase pathway (BcsABZC).
Genes represented in pink encode proteins responsible for O-acetylation of cellulose that are
homologous to alginate O-acetylation proteins (AlgFIJ).
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Figure 6: Schematic Representation of the Acetylated Cellulose Exopolysaccharide Synthase
Dependent Systems.
The modified cellulose polymer depicted by glucose units (blue circles). Wss proteins
homologous to Bcs proteins responsible for synthesis and export are highlighted in blue, and
Wss proteins homologous to the alginate acetylation proteins are depicted in pink. A proposed
path of the acetyl donor is represented in black.
Acetylated cellulose synthesis is predicted to occur by processes similar to the cellulose
and alginate pathways (routes and mechanism surmised in Figure 2 and 6) and each of the
genes/proteins have sequence identity at the nucleotide and amino acid levels. Briefly, WssB is
analogous to BcsA/Alg8-Alg44 and therefore is predicted to be activated by the secondary
messenger c-di-GMP to polymerize the UDP-glucose into a multi-unit chain20. WssC is
analogous to the BcsB/Alg8 proteins that guide the polymer into the periplasmic space, while
WssD cleaves the cellulose chain as it is predicted to be an endoglucanase protein, like BcsZ and
AlgL20. Lastly, WssE is hypothesized to have similar function to BcsC/AlgK-AlgE as its amino
acid sequence is predicted to adopt TPR folds that are fundamental for protein interactions in the
complex. WssE is also predicted to be the outer membrane pore that facilitates export outside of
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the cell20. Similar to the alginate pathway, a subset of the genes (wssFGHI) within the operon
encode for proteins that are predicted to modify the cellulose polymer with acetyl groups.
Homologous to AlgX/AlgFIJ, the Wss proteins are predicted to acetylate cellulose in a similar
process by transferring the acetyl group into the periplasmic space from a donor protein (WssH)
and attaching the group onto microbial cellulose by the concerted action of WssFGHI
(mechanism unknown)20. Lastly, WssA and WssJ (not shown in Figures 2, 5 and 6) are
homologous to MinD and are proposed to be responsible for correct spatial localization of the
complex22.
Although the function of the Wss proteins involved in the acetylation and secretion of
cellulose are predicted based on homology, Spiers and colleagues (2003) demonstrated the
effects of WssFGHI mutants in relation to the in vivo biofilm of P. fluorescens. A polar mutant
of the gene encoding WssF (wssF-) was created by the insertion of the mini-Tn5 transposon at
the wssF location, thereby having an effect on downstream gene expression of proteins
WssGHI22. Once the mutant strain was grown on agar and in liquid media, colonies
demonstrated a smooth phenotype compared to the wrinkly spreader phenotype of wild-type
WssF (Figure 7-Left)20,22,36. The wrinkly spreader colony morphology was depleted and the
prominent biofilm layer at the air-liquid interface was disrupted despite the fact that cellulosic
material was still produced (Figure 7-Right). The genetic mutants of the WssFGHI proteins
hindered the ability of the biofilm to spread, adhere to surfaces and maintain a robust biofilm36.
These results suggest that these genes could have an overall effect on the virulence of this
organism that is directly related to the acetylated cellulose pathway.
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Figure 7: Non-Acetylated Cellulose Biofilm Phenotype from a wssF Mutant.
(Left) Colony morphology of the P. fluorescens mutant (wssF-) grown on LB containing Congo
Red agar. (Right) Phenotype of the P. fluorescens mutant (wssF- ) biofilm formed at the airliquid interface in King Broth incubated for 3-7 d at 28 ℃22. Figure rendered from Spiers et al.
2003.
1.5.1. Membrane-Bound O-Acyltransferases
Membrane bound O-acyltransferases (MBOATs) are a family of membrane spanning
acyltransferases responsible for carrying out the transfer of acyl (RCO-) groups onto a polymer.
This family of proteins contain a functional domain located within the membrane and share two
common active site residues, histidine and asparagine18. The histidine residue is embedded in a
long series of hydrophobic residues, while asparagine is located within a hydrophilic region18.
Eukaryotic MBOATs are predicted to have 8-12 transmembrane helices that localize secretory
pathways (ER/Golgi complex)37.This family of membrane bound proteins was identified by
Hoffman in 2000, after analysis of sequence alignments in wingless Drosophila37,38. Over 7000
MBOAT proteins have been identified since this discovery including bacteria and vertebrates39.
MBOATs have been categorized into three biochemical reactions: acylation of -OH moiety of
cholesterol or diacylglycerol, acylation of an amino acid within a protein or peptide and
acylation of a lysophospholipid to form a phospholipid18. Relevant to this research, a study by
Xu and co-workers, characterized the structure of a Gram-positive protein, DltB that is
responsible for D-alanylation of cell-wall teichoic acids. The findings by Xu and co-workers
established the structure-function relationship of DltB, by which a mutation of the conserved
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histidine residue abolishes the alanylation of lipoteichoic acids and sensitizes the bacteria to cell
wall stress39. This information is important when understanding the mechanism of action and
inhibition profiles of other MBOAT proteins that also have the conserved active site histidine
residue, including MBOAT domains of homologous proteins involved in acetyltransfer (ex.
Gram-negative proteins PatA1 and PatA2 responsible for peptidoglycan acetylation and AlgI
involved in alginate acetylation)34,40,41. While not characterized, WssH is the predicted MBOAT
protein in the Wss system, with 99% identity to the plant pathogen Pseudomonas syringae
MBOAT family42. Section 1.5.1.1. will discuss these proteins and their associated role in the
acetyltransfer reaction, which initiates the acetyltransfer relay in the Wss system.
1.5.1.1.

Polysaccharide Acetyltransferases

An identified purpose of O-acetylation of polysaccharides used by pathogens is to protect
against external stress, thereby improving persistence of these organisms within a biofilm and
exacerbating chronic infections. As previously mentioned, AlgF, AlgIJ/ and AlgX are
hypothesized to be involved in modifying alginate with an acetyl group, where AlgJ and AlgX
acetyltransferase proteins34. The acetyl group cleaved from a donor (unknown) is proposed to be
transported across the cytoplasmic membrane by MBOAT AlgI, and shuttled towards the
alginate chains through the coordinated action of either AlgJ and/or AlgF33,34,43. One proposal is
that the acetyl group is then transferred to AlgX by the help of intermediate protein AlgJ, and Oacetylation of alginate occurs in the periplasm prior to secretion outside of the cell34.
Other O-acetyltransferase proteins from Gram-negative species of Campylobacter,
Helicobacter, and Neisseria modify peptidoglycan with acetate to control their autolysis by
blocking the activity of lysozymes, which hydrolyze the backbone glycosidic linkages of
peptidoglycan (PG)44. PG O-acetyltransferases transfer acetyl groups onto the C6 hydroxyl
position on the muramoyl units of the polymer of peptidoglycan45. This transferase activity is
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hypothesized to be carried out by membrane bound O-acetyltransferase (MBOAT) protein, PatA
in combination with PatB40,45–48. The reaction is hypothesized to be initiated by PatA
translocating an acetyl group from the cytoplasmic space cleaved from an unknown donor into
the periplasm where PatB utilizes Ser-Asp-His catalytic residues to transfer the group onto the
C6 hydroxyl of muramoyl units outlined by Moynihan and Clarke (2014) (Figure 8) 41,43–45. In
Gram-positive systems (Bacillus) PatB1transfers an acetyl group onto secondary cell wall
polysaccharides (SCWP), while Staphylococcus aureus and Streptococcus pneumoniae also
contain O-acetylated peptidoglycan carried out by protein OatA, which was discovered as the
factor contributing to lysozyme resistance 40,46,49–51. The N- and C-terminal domains of OatA are
hypothesized to translocate and transfer the acetyl group onto the polysaccharide in a similar
mechanism performed by both PatA and PatB in a Ping-Pong Bi-Bi kinetic mechanism of
action41,52. All of the listed O-acetyltransferase proteins catalyze the modifications by the SerAsp-His catalytic triad, which is also the predicted mechanism of WssI due to homology
between acetyltransferase proteins and conserved catalytic residues.
1.5.1.2.

Mechanism of Action

The mechanism of action of the previously mentioned O-acetyltransferase proteins is
carried out by the three conserved catalytic residues accompanied by an oxyanion hole for
stabilization (see Figure 8). The reaction occurs in two subsets. The first reaction is the cleavage
of the ester bond of the acetyl donor, which is initiated by a salt bridge formed by the carboxyl
group of Asp to the ring nitrogen of histidine (Figure 8: Panel A). A proton relay occurs to attract
a proton from the functional group of serine to the other ring nitrogen of histidine, allowing
serine to attack the carbonyl carbon of the acetyl donor (Figure 8: Panel A and B). The
tetrahedral intermediate releases the product, when the acceptor (sugar or water molecule) binds
to the active site cleft (Figure 8: Panel B and C). The transfer onto water or a glucose unit occurs
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by acid-base catalysis where the histidine residue attracts the proton of the C6 hydroxyl group,
forming another tetrahedral intermediate (Figure 8: Panel D and E). The catalysis then allows the
C6 alkoxide on the carbonyl centre of acetyl serine to attract and release the acetyl group, which
is now attached to the acceptor (Figure 8: Panel F). The amino acid homology/ conservation of
the WssI proteins in relation to the Alg and Pat proteins suggest that WssI catalyzes a similar
reaction onto the cellulose substrate (see Figure 8).
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Figure 8: Proposed Mechanism of Action of Esterase and Transferase Activity of WssI.
The activity of O-acetyltransferases consists of an esterase reaction with substrate p-nitrophenyl
acetate (transfers acetyl group onto water), or a transferase reaction (transfers acetyl group onto a
glucose unit). Catalytic residues serine (red), histidine (green) and aspartate (blue) are outlined as
the catalytic triad. The amine group of serine, glycine and asparagine are represented in light
blue as the oxyanion hole. The acceptors in an esterase or transferase reaction is outlined in grey
as a water molecule or a glucose substrate. Figure rendered from Moynihan and Clarke (2014)
and Sychantha, et al (2018).
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2. Research Need
The rise of antibiotic resistance in active bacterial species within biofilms presents an
urgency for biofilm research. Research is needed on a microbial and molecular level due to the
adaptation of these opportunistic species that leads to persistent infections. The US Centers for
Disease Control and Prevention (CDC) estimated that 1.7 million infections requiring
hospitalization each year were acquired from microorganisms within a persistent biofilm (US
CDC, 2007). These infections resulted in a catastrophic $11 billion in estimated total health care
costs (US CDC, 2007). Techniques used to properly diagnose and treat biofilm-related infections
are a challenge because the pathogenic microbes are sheltered inside the biofilm and are resistant
to typical antimicrobial therapies. Additional research is needed to further understand harmful
and advantageous biofilms, which in turn would enhance diagnostic guidelines and techniques in
conjunction with modifying/creating antimicrobials or biomarkers that can recognize and target
bacteria within a biofilm53. Understanding the molecular mechanics of infections biofilms could
improve diagnostic tools and strategic treatment options, while maintaining microbiome health
from traditional methods, such as antibiotic administration.
Specific to this project, two Gram-negative microbial species, Pseudomonas fluorescens
and Achromobacter insuavis are under investigation for their ability to produce acetylated
cellulose biofilms. Select species of Pseudomonas are human pathogens most commonly known
for bacterial infections within the airway of Cystic Fibrosis patients (P. aeruginosa)29,54-55.
Although P. fluorescens is often considered to be less pathogenic than P. aeruginosa, clinical
studies have found this pathogen to persist in infected human organs and tissues (i.e., the uterus,
urinary tract, skin, sinus, lungs, eye, cerebrospinal fluid, bone and most commonly the blood)56.
Pseudomonas can also be responsible for causing spoilage of pasteurized liquid milk products,
fruits, vegetables and meats57. However, it should be noted that colonization by P. fluorescens
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can also lead to advantages for some hosts. For example, P. fluorescens is used as a biocontrol
factor by producing antibiotic compounds, such as phenazine-1-carboxylic acid (PCA) and
hydrogen cyanide (HCN), to supress wheat and tobacco plant wilting caused by fungal
pathogens58. The combined advantages and disadvantages of P. fluorescens biofilms provide a
unique and valuable opportunity to use this organism as a model to better understand the
exopolysaccharide it produces and the wider scope of biofilm relevance.
While P. aeruginosa is often the focus of CF lung infections, Achromobacter can also
colonize and infect the lung mucosae of CF patients. Specifically, A. insuavis and A.
xylosoxidans have been identified as emergent pathogens that form a strong biofilm within the
sputum of CF patients in nosocomial environments59,60. A. xylosoxidans is most prevalent within
the biofilm of CF patients and this pathogen has exhibited antimicrobial resistance, with 70% of
clinical strains studied presenting resistance to aminoglycoside antibiotics59. Achromobacter can
also be found within the human body on organs and tissues and are the predominant colonizer of
contact lenses, solutions and cases60,61. Contamination of A. xylosoxidans on contact lenses has
been linked to being the main cause of bacterial-related keratitis of the eye (inflammation of the
cornea)61. The persistence of this infection to commonly used healthcare tools adds to the rising
healthcare costs from biofilm related diseases, which enhances the importance of this research
due to the normalized use of contact lenses as an alternative to glasses. Therefore, healthcare cost
may be mitigated through a better understanding of how this organism forms biofilms and
persists in specific environments other than internal organs not readily exposed for treatment.
Interestingly, understanding the growth of Achromobacter as a biofilm additionally has
beneficial applications similar to that of P. fluorescens. A. xylosoxidans has also been identified
to supress tomato wilt caused by the fungal plant pathogen Fusarium62. This finding expands the
needs for biofilm research, as the species that would present pathogenesis in one environment,
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may be beneficial to another. Given that both of these organisms possess the cellular machinery
(i.e., wss genes and proteins) to produce a robust acetylated cellulose biofilm, this provides a
common link to investigate the many effects of these organisms when they adopt this mode of
growth. While genetic studies have linked the WssFGHI proteins to cellulose acetylation,
structural and functional evidence of the role/ activity of these proteins is missing. Thus, the
biochemical characterization of the putative acetyltransferase, WssI, would greatly improve our
understanding of how the cellulose polymer may be modified. Currently, potential inhibitors to
combat the robust biofilm infections is also limited, so the proposed work holds additional
potential to lead to the mitigation/control of acetylated cellulose containing biofilms, while also
broadening existing knowledge of homologous acetyltransferase from other bacterial
carbohydrate biosynthetic systems (i.e., peptidoglycan, cellulose, alginate and others).

3. Hypothesis and Objectives
I hypothesized that WssI is an O-acetyltransferase involved in the acetylation of
microbial cellulose produced by P. fluorescens and A. insuavis. Support for this hypothesis
was based on the shared amino acid identity (29%) and similarity (47%) of WssI to the
esterase/transferase protein AlgJ, involved in bacterial alginate acetylation, which contains
conserved active site residues. Spiers and coworkers also suggested a role for this protein in
cellulose acetylation by incorporating polar mutations via transposon mutagenesis, thereby
affecting the downstream expression of the wssFGHI genes22. However, WssI had never been
biochemically characterised to prove this role. The hypothesis that WssI is a cellulose
acetyltransferase was specifically tested in this thesis by utilizing existing E. coli based plasmid
expression constructs (made by prior lab members) to 1) optimize expression and purification of
recombinant WssI; 2) gain insight into WssI selectivity with various acetyl donors and cellulose
polymers; 3) analyze and verify cellulose acetylation activity by WssI and 4) screen various
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chemical compounds to identify potential catalytic inhibitors of WssI that may lead to the
development of anti-acetylation or possibly antimicrobial agents. These specific aims were
examined through the following objectives:
Objective 1: Protein Expression and Purification
The optimization of the expression and purification of WssI was required to improve a)
the overall yield and b) purity of the protein for large-scale assays that required an abundance of
protein for confidence in the reported data. This objective specifically examined E. coli BL21
expression hosts, induction times and sequential purification techniques to increase overall yields
and purity.
Objective 2: Characterize the Function of WssI
The in vivo acetyl donor utilized by the Wss and Alg proteins is unknown. However,
commercial substrates with acetyl leaving groups and a detectable core structure have been
useful as pseudo-donors to assess activity of other O-acetyltransferases. For example, 4methylumbelliferyl acetate (4-MUB-Ac) in fluorescence-based assays and p-nitrophenyl acetate
(pNP-Ac) for colourimetric assays have proven useful63. The kinetic parameters and specific
activities for the initial portion of the acetyltransferase reaction of WssI (i.e., esterase activity
determined by cleaving ester bond and transferring the acetyl group to water rather than a
carbohydrate) can be determined using these donors and also utilized to probe the optimal pH,
common mechanistic inhibitors and stabilizing agents.
The length of the cellulose polymer was varied to determine if WssI exhibits selectivity
(observed via specific activity) for acetylating a particular size of cellulose polymer. I
hypothesized that WssI would prefer longer cellulose polymers, because a longer acceptor would
mimic a polymer more similar to microbial cellulose being synthesized and exported in vivo.
This experiment was followed up using chitin oligomers to verify specificity toward cellulose
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polymers to prove that WssI only acts on cellulose. Avicel was used to mimic microbial cellulose
to assess binding interactions between WssI and a cellulose variant. Lastly, an additional
endeavour was attempted to mutate the genes encoding three catalytic residues of WssI and
assess remaining activity to better understand the contribution of each residue. These activity
experiments were combined the use of thin layer chromatography (TLC) and mass spectrometry
(MS) to visualize the success/ progress of the acetyltransfer reaction.
Objective 3: High-throughput Screening of WssI for Potential Inhibitors
The SPARC BioCentre at SickKids Toronto was used for the High Throughput Screening
(HTS) of WssI against potential inhibitors. In other carbohydrate acetyltransferase assays, the
use of 4-methylumbelliferyl acetate as an acetyl-donor has been amenable to high-throughput
analysis. Using the results of objective 1 with this donor, I assessed specific high-throughput
parameters (Zʹ, assay length and enzyme amount) to create a standard assay for WssI at the HTS
facility. A series of primary, secondary, dose response and fluorescence quenching trials were
followed to assemble a list of the best inhibitory compounds for WssI. Following these trials, the
compounds were further verified as potential inhibitors and efficacy determined with IC50
curves. The findings may be useful for further studies to develop anti-acetylation or
antimicrobial agents to test against biofilms formed by P. fluorescens and A. insuavis.

31

4. Materials and Methods
4.1. Chemicals and Reagents
All chemicals and reagents were obtained from Fisher Scientific (Nepean, ON) unless otherwise
noted. Exceptions include tryptone powder, yeast extract, lysozyme, all antibodies, Western blot
development solutions, 2-(N-morpholino) ethanesulfonic acid (MES) buffer salt, and dimethyl
sulfoxide (DMSO), which were purchased from BioShop (Burlington, ON).
Chemicals and reagents from BioBasic (Markham, ON) include agar A, kanamycin and
chloramphenicol, dithiothreitol (DTT), isopropyl 𝛽-D-1-thiogalactopyranoside (IPTG), glycerol,
RNaseA and DNaseI, imidazole, acrylamide, glycine and skim milk powder. Sigma Aldrich (St.
Louis, MO) was the manufacturer of sodium phosphate, p-nitrophenyl acetate (pNP-Ac), 4methylumbelliferyl acetate (4-MUB-Ac), phenylmethanesulfonyl fluoride (PMSF), methane
sulfonyl fluoride (MSF), pepstatin A, acetyl CoA, avicel, ethylenediaminetetraacetic acid
(EDTA), acetonitrile, ethyl acetate, 𝛼-naphthol, diphenylamine, aniline, phosphoric acid and
acetone. Aluminum-backed thin layer chromatography (TLC) plates, ammonia solution and E-64
were from MilliPore (Burlington, MA) and ethanol was purchased from Commercial Alcohols
(Brampton, ON). EDTA-free Protease inhibitor tablets were from Thermo Scientific (Waltham,
MA) and triton X was from MP Biochemicals, LLC. (Solon, OH). Nitrocellulose membrane and
Precision Plus protein ladder was from BioRad (Hercules, CA), while cellulose and chitin
oligomers were purchased from Megazyme (Chicago, IL). Chemical inhibitors were purchased
from MolPort (Latvia) or Enamine (Monmouth, NJ). Lastly, competent cells were from Agilent
(Santa Clara, CA).
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4.2. Expression and Purification of WssI
4.2.1. Bioinformatic Analysis
Bioinformatic searches for WssI were conducted using multiple open source online tools
with the amino acid sequence of the full protein (obtained from the NCBI database, Accession
number: WP_012721729) and the soluble truncated derivatives missing the N-terminal
transmembrane region. ProtParam was used to obtain information regarding protein stability,
isoelectric point, and extinction coefficient values64. This information was used when obtaining
protein concentration values and optimizing anion exchange purification protocols. The Phyre2
server and BLAST were used to align the amino acid sequence of WssI with other published
protein models65. This provided information regarding hypothetical functions and a predicted
secondary/tertiary structure of WssI based on percent identity of proteins with solved structures.
A combination of Clustal Omega and PyMol outlined conserved active site residues from
homologs of WssI through sequence and 3D model alignments66,67. The combination of the
various bioinformatic tools offered important characteristics regarding predictive properties of
WssI.
4.2.2. WssI Expression Constructs
All expression constructs had been created prior to the onset of the present research.
Briefly, the construct of wssI from Achromobacter insuavis was ordered from Genscript biotech
in a pET24 plasmid vector in frame with a coding sequence for a six-histidine residue tag located
on the carboxyl terminus (pAiWssI-His6) of the expressed AiWssI protein. The plasmid construct
of AiWssI consists of the gene region lacking the N-terminal transmembrane section, so only the
predicted soluble domain of WssI was produced (amino acids 95 to 380). Similarly, the wssI
gene from Pseudomonas fluorescens (PfWssI) was successfully cloned by a former lab member
(Janice Prescod) into a pET28 plasmid vector with a C-terminal His6-tag (pPfWssI-His6)
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containing the comparable soluble domain from this organism (amino acids 92 to 374). In
addition, N-terminal His-tag clones for both WssI constructs in pET28 plasmid vectors were
cloned by Ms. Prescod successfully (pHis6-AiWssI and pHis6-PfWssI). Only the C-terminal His6tagged constructs were used in this project, however, both C-and N-terminal constructs have a
molecular weight of approximately 32 kDa.
4.2.3. Site Directed Mutagenesis
The purpose of site directed mutations of the three putative catalytic residues (histidine,
aspartate and serine) was to explore the role of these residues involved in the proposed
acetyltransfer carried out by WssI. The residues of PfWssI S304, D205, H207 and AiWssI S309,
D209 and H211 were replaced with alanine by site directed mutagenesis of the wssI gene.
Primers used for this mutation are listed in Table 1. Mutagenesis was carried out using the
pPfWssI-His6 and pAiWssI-His6 as a template for pfu Ultra DNA polymerase according to
Agilent Technologies QuikChange II site directed mutagenesis (SDM) kit (Santa Clara, CA)
according to the manufacturer’s specifications, with the exception of adding 4% (v/v) DMSO for
touchdown PCR reactions. Appropriate positive controls were done utilizing the pWhitescript
plasmid with corresponding forward and reverse primers provided by the SDM kit. Following
PCR, 1µL of Dpn1 was added to the 50 µL PCR mixture and incubated at 37 ℃ for 1 hr to
degrade any methylated DNA from the original template. The resulting plasmids were used to
transform E. coli Top10 cells, and clones were screened for the correct mutations by DNA
sequencing at the TCAG DNA Sequencing Facility at SickKids Toronto. These mutants were
transformed into E. coli BL21 Rosetta codon plus cells, expressed and purified utilizing the same
protocol optimized for the native protein (See Sections 4.2.4. and 4.2.5.). Care was taken to use
new chromatography media for each purification to preclude potential contamination of the
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various mutant and wild type forms. The pure protein was later used for functional assays to
examine remaining activity of protein knockouts.
Table 1: Primers Sequences for PfWssI and AiWssI Serine, Aspartate and Histidine Point
Mutations.
Mutation**
Primer Sequence (5ʹ -3ʹ)*
PfWssI_S304A Fwd2
GCTGATCGGCACGGCATTCTCGCGTAAC
PfWssI_S304A Rev2
GTTACGCGAGAATGCCGTGCCGATCAGC
PfWssI_D205A Fwd2
CTACCTGCGTACCGCGACCCACTGG
PfWssI_D205A Rev2
CCAGTGGGTCGCGGTACGCAGGTAG
PfWssI_H207A Fwd2
CTGCGCACTGACACCGCCTGGAGGAG
PfWssI_H207A Rev2
CTCCTCCAGGCGGTGTCAGTGCGCAG
AiWssI_S309A Fwd2
CCTGGTGGGTACCGCTTTTTCCCGTAC
AiWssI_S309A Rev2
CGTACGGGAAAAAGCGGTACCCACCAGG
AiWssI_D209A Fwd2
CGTATTACCGCAACGCAAGCCACTGGACC
AiWssI_D209A Rev2
GGTCCAGTGGCTTGCGTTGCGGTAATACG
AiWssI_H211A Fwd2
CCGCAATGATAGCGCCTGGACCGAAGC
AiWssI_H211A Rev2
GCTTCGGTCCAGGCGCTATCATTGCGG
*Highlighted codon represents the alanine point-mutation.
** AiWssI denotes WssI construct from Achromobacter insuavis and PfWssI denotes WssI
construct from Pseudomonas fluorescens
4.2.4. Expression of WssI
Chemically competent E. coli Top10 were used as the host strain for propagating
plasmids, and once transformed, cells were plated on Lysogeny Broth (10 g tryptone, 5 g yeast
extract, 10 g NaCl, 7.5 g agar) agar with kanamycin (final concentration of 50 µg/mL) to select
for successful transformants containing recombinant plasmids with the kanamycin resistance
marker. A 5 mL liquid culture of Lysogeny Broth (LB) containing kanamycin (final
concentration of 0.1%) was inoculated and grown for 16-18 hrs at 37℃, with shaking at 240 rpm.
The culture was then used for a Plasmid Mini or Midiprep as per manufacturer’s instructions
(BioBasic EZ-10 Miniprep Kit and Thermo Scientific GeneJET Plasmid Midiprep Kit). Each
purified plasmid sample was frozen at -20℃ in 50 µL aliquots until needed.
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For protein expression, plasmid samples were thawed and transformed into chemically
competent E. coli BL21 (Rosetta Codon Plus) and selected for successful transformants by
plating on LB-agar containing kanamycin and chloramphenicol (final concentration of 50 µg/mL
in water and 34 µg/mL in ethanol). This strain of E. coli was selected for expression because it
contains the T7 RNA polymerase/promoter system that works with the isopropyl 𝛽-D-1thiogalactopyranoside (IPTG) inducible lactose-expression system on the pET series of plasmids
that contain the wssI construct. Once transformed, starter cultures were created from an E. coli
BL21 colony containing a recombinant construct inoculated into 10 mL of LB broth containing
kanamycin and chloramphenicol (final concentration of 50 µg/mL and 34 µg/mL) and grown for
16-18 hrs at 37 ℃ with shaking at 240 rpm. The 10 mL starter culture was then added to 1 L of
pre-warmed super broth growth media (SB) (35 g tryptone, 20 g yeast extract and 10 g NaCl and
supplemented with 50 µg/mL of kanamycin and 34 µg/mL of chloramphenicol). The culture was
incubated at 37℃ with shaking at 240 rpm until the optical density at 600nm (OD600nm) of culture
was 0.6 (as measured in an Evolution 605 UV-Vis spectrophotometer- Thermo Scientific), which
is an indicator that the bacterial cells are reaching the exponential phase of growth that can lead
to efficient protein production. At this time, 200 µL of the growing culture was transferred to a
microcentrigue tube as a time zero (T=0) sample for SDS-PAGE analysis (see Section 4.2.5.2.)
To the growing expression culture, IPTG was added to a final concentration of 1 mM and the
culture was grown for another 16-18 hrs at 17 ℃ with shaking at 240 rpm. At this point, another
SDS-PAGE sample was obtained as a post-inducible sample (T=ON) and treated as the same as
the time zero sample above. The rest of the expression culture was subjected to centrifugation
using a Beckman Coulter Avanti J-30I centrifuge at 5000 xg for 15 min at 4 ℃. Cell pellets were
kept and transferred into conical tubes prior to storage at -20 ℃ until protein purification was
attempted.
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4.2.5. WssI Purification
The protein purification steps were specifically designed to extract the protein that was
produced by the E. coli Rosetta Codon plus cells. Plasmid constructs were all prepared so that
expressed WssI would be in frame with C-terminal His6-tag that serves as an affinity tag for an
initial purification step, Immobilized Metal Affinity Chromatography (IMAC). Specifically,
nickel-nitrilotriacetic acid (Ni-NTA) with immobilize nickel columns (5 mL HisTrap FF column,
GE Healthcare) have affinity for the His6-tag of WssI; thereby allowing this protein to bind while
other contaminating proteins in the sample will be washed away. The target WssI-His6 tagged
protein can then be competed off the column with an increasing gradient of imidazole, an analog
of a portion of the sidechain of histidine.
To begin the purification process, bacterial cells were thawed and suspended in buffer A
(50 mM Tris, 500 mM NaCl, 1 mM DTT, 2% (v/v) glycerol pH 7.5) including RNase (final
concentration of 16 µg/mL), DNase (final concentration of 8 µg/mL), one dissolved EDTA-free
protease inhibitor tablet, 20% (w/v) lysozyme and 0.1% (v/v) triton-X. The bacterial suspension
was incubated on a rocking platform at 4 ℃ for 30 min to ensure a homogenous solution. The
cells were then mechanically lysed by passing the sample twice through a constant cell
disruption system (Constant Systems Ltd.) at 17 kpsi. Unwanted large cellular debris was
removed through centrifugation at 28,000 xg for 45 min at 4 ℃ and the clarified soluble cellular
lysate was retained. An SDS-PAGE sample was obtained from the cleared lysate in a 1:1 ratio
for later analysis. The cleared lysate was then diluted using buffer B (buffer A containing 500
mM imidazole) to a final concentration of 20 mM imidazole, maintaining a low presence of
imidazole to prevent unwanted contaminants from binding to the column. Using an AKTA Start
Fast Protein Liquid Chromatography (FPLC) system the lysate was applied to a 5 mL HisTrap
FF column (GE Healthcare Life Sciences) twice, at a flow rate of 1-2 mL/min. The column was
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washed with 3 column volumes (CVs) of buffer A. An SDS-PAGE sample was obtained from
the wash in a 1:1 ratio with 5X SDS sample buffer for later analysis. Bound protein was eluted
from the column by applying 4 CVs of 90% Buffer A and 10% of buffer B. A final elution step
of 10 CVs of 100% buffer B was applied to remove any remaining protein. All samples were
collected in 2 mL fractions and fractions containing the desired WssI-His6 tagged protein and
were pooled together based on the FPLC chromatogram profile. SDS-PAGE samples were
obtained from each peak in a 2.5:1 (sample to 5X SDS buffer) ratio for downstream SDS-PAGE
analysis.
4.2.5.1.

Protein Dialysis

Within the protein elution buffer, high concentrations of NaCl and imidazole are present
that were removed prior to downstream analysis. High amounts of NaCl and imidazole can
hinder the activity and stability of WssI but can be removed easily through dialysis. A buffer
containing 100 mM sodium phosphate (pH 7.0), 150 mM NaCl, 2% (v/v) glycerol and 1 mM
DTT was used for dialysis. The pooled IMAC elution fractions that included WssI were
transferred into the dialysis tubing (Fisher Scientific Regenerated Cellulose Dialysis Tubing,
MWCO 14,000 Da) and exchanged at 4 ℃ with gentle stirring for approximately 1 hr, upon
which the buffer was replaced and allowed to dialyze for another 16-18 hrs. The protein was then
transferred into a VivaSpin20 concentrator (Sartorius) with a 10 kDa molecular weight cut off
(MWCO) and concentrated at 4,000 xg in a Beckman Coulter Allegra X14R centrifuge until a
volume of approximately 1 mL was reached. The concentration of the protein in the sample was
measured A280nm using the Gen5 program (settings include the molar extinction coefficient of
WssI: 33585 M-1cm-1) on a Cytation 5 microplate reader (VWR), using the dialysis buffer as a
blank.
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4.2.5.2.

SDS-PAGE Analysis

SDS-PAGE analysis was run after expression and purification experiments to follow the
presence and purity of the protein samples. Both the expression and purification samples were
subjected to DTT and SDS, which reduce disulfide bonds, denature the protein’s secondary
structure and supply a net-negative charge-to-mass ratio for separation. This procedure was
performed to separate proteins based on molecular weight and compared to a standard protein
ladder (Precision Plus Protein Standard, BioRad).
For SDS-PAGE analysis, expression samples (time zero and post induction) were
pelleted in a centrifuge at maximum speed (21,100 xg) for 5 min in a Legend Micro 21
Centrifuge (Thermo scientific). The media was decanted, and the sample pellet was then
suspended in 5 times concentrated SDS-PAGE sample buffer (2M Tris-HCl pH 6.8, 50% (v/v)
glycerol, 1% (w/v) SDS, 0.2% (w/v) bromophenol blue and 10mM dithiothreitol (DTT)). All
samples where heated at 90-100 ℃ for approximately10 min prior to loading onto a 12% (v/v)
SDS-PAGE gel. Separation of proteins in the gel was achieved by applying 180 V to the gel for
45 min. Following separation, proteins in the gel were stained with Coomassie Brilliant Blue
(0.1% (w/v) coomassie R250, 10% (v/v) acetic acid and 40% (v/v) methanol) and then placed in
a destain solution (20% (v/v) methanol, 10% (v/v) acetic acid and 70% (v/v) milli-Q water) until
desired contrast was achieved. The gel was imaged using a VersaDoc imaging system (BioRad),
and samples containing WssI were evidenced by a band present at the appropriate size (32 kDa).
4.2.5.3.

Western Blot Analysis

A Western blot analysis was done to confirm the presence of WssI throughout the
purification process and to visualize if/where WssI may have been lost in other purification
fractions. This experiment utilized the His-tag located on the C-terminus of the protein as the
target for the primary antibody to bind for later detection. The proteins and ladder on the SDS-
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PAGE gel were transferred onto nitrocellulose membrane in transfer buffer (12 mM Tris, 96 mM
glycine, 20% (v/v) methanol) at 4 ℃ at 100 V for 80 min. The nitrocellulose membrane was
rinsed with 1 X TBS (10 mM Tris pH 7.5, 150 mM NaCl) buffer and blocked with 5% (w/v)
blocking buffer (skim milk powder in 1 X TBS) for 1 hr, while gently agitated on a shaking
platform. The membrane was rinsed twice with 1 X T-TBS buffer (20 mM Tris pH 7.5, 2 mM
NaCl, 0.05% (v/v) tween-20) for 5-10 min. The anti-His tag mouse monoclonal primary antibody
(1:1000, BioShop) was applied to the membrane and incubated while shaking for 1 hr to allow
the antibodies to bind to the His-tagged protein. The membrane was rinsed prior to the
incubation of the goat anti-mouse alkaline phosphatase conjugate secondary antibody (0.5:1000,
BioShop) for 1 hr, while gently agitated on a shaking platform. The membrane was rinsed
thoroughly with 1 X T-TBS, followed by 1 X TBS to remove any tween residue. The blot was
developed with alkaline phosphatase substrate solution (BCIP/NBT solution, BioShop) for less
than 1 min to allow the colourimetric reaction to occur between the secondary antibody
conjugate alkaline phosphatase enzyme and the developing substrate solution. Alkaline
phosphatase hydrolyzes BCIP, which forms an intermediate that undergoes dimerization to
produce an indigo dye at the location in which the primary antibody bound to the His-tagged
protein68.The NBT in the solution is then reduced by the reaction intermediate producing two
reduced equivalents by dimerization68. The reaction was stopped through the addition of water
when the desired contrast was achieved.
4.2.5.4.

Anion Exchange

The secondary purification method of anion exchange was utilized to improve purity of
WssI for later functional assays. The theoretical pI of WssI is 6.3, implying a relative negatively
charged protein, which binds to positively charged resin. The protein was purified utilizing a salt
gradient with an optimal buffer pH around 7.5. The gradual increase in salt allows the chloride
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anions to compete for the binding sites on the positively charged resin, progressively eluting any
protein that was previously bound. Prior to anion exchange, the IMAC fractions containing WssI
were dialyzed into 50 mM Tris pH 7.5, 1 mM DTT, and 2% (v/v) glycerol, as outlined above, to
ensure that all residual imidazole and salt are removed and do not interfere with binding to the
anion column. The anion exchange 5 mL HiTrap Q FF column (GE Healthcare Life Sciences)
was equilibrated in Buffer C (50 mM Tris pH 7.5, 1 mM DTT, and 2% (v/v) glycerol), prior to
the addition of the dialyzed protein, which was passed over the column approximately 4-5 times
with increasing flow rates from 0-5 mL/min, using the AKTA FPLC to permit adequate binding
time. Purification was conducted over 6 column volumes of 0-100% buffer D gradient
(containing the same components as buffer C, but with the addition of 500 mM NaCl as the
eluting agent). Fractions were pooled for analysis on an SDS-PAGE gel and the presence of
WssI was confirmed based on a band of appropriate mass. Following anion exchange, the peak
on the chromatogram and/or fractions from the SDS-PAGE gel that corresponded to the purest
form of WssI were dialyzed into 100 mM sodium phosphate (pH 7.0), 150 mM NaCl, 2% (v/v)
glycerol and 1 mM DTT to stabilize the protein for later functional assays.

4.3. Characterizing WssI Activity
4.3.1. Esterase Activity of WssI
A preliminary assay was done to test the activity of WssI against the acetyl donor pnitrophenyl-acetate (pNP-Ac). The reaction indicates WssI has esterase activity, which results in
the cleavage of the ester bond of pNP-Ac, with acetyl as a leaving group and the released pnitrophenol group could be quantified at 405 nm due to its yellow chromogenic properties
(Reaction in Figure 8). The assay was performed in a 96 well microplate format (Sarstedt
Microtest plates) with a final volume of 150 µL. Reaction buffer consisted of 50mM sodium
phosphate buffer (pH 7) and concentrations of WssI ranging from 0.5-15 µM. Reactions were
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initiated by the addition of pNP-Ac to a final concentration of 2mM (final concentration of
ethanol in reaction was 5% (v/v) as this was the solvent for pNP-Ac). Assay samples and
corresponding controls (i.e., containing no WssI) were run in quadruplicate and analyzed for
absorbance at 405 nm (Cytation5) for 30 min in 1 min intervals following a 5 s initial linear
shake to mix contents thoroughly. The listed conditions were standard assay conditions for
subsequent trials unless mentioned otherwise. A second donor, 4-MUB-Ac, was also tested as a
substrate of WssI for its amenability to the planned high throughput analyses (see Section 4.5.).
Briefly, reaction setups were exactly the same as that for pNP-Ac, with the exception that 4MUB-Ac (final concentration of 0.5 mM in 5% (v/v) DMSO as this was the solvent for 4-MUBAc) was the acetyl donor and the assay was performed in fluorescence compatible 96-well plates
(Grenier BioOne) and monitored with excitation and emission wavelengths of 365 and 450 nm,
respectively for 90 min. Specific activity was reported as 1 unit of esterase activity, which was
defined as the amount of enzyme required to release µmol of p-nitrophenol min-1
(mg of protein)-1.
4.3.2. pH Profiles
The optimal pH and buffer type compatible for activity assays was assessed by observing
the activity of WssI in various conditions. A 2-(N-morpholino)ethanesulfonic acid (MES) buffer
was chosen between pH ranges of 5.5-6.5, sodium phosphate buffer for pH of 6.5-7.5 and Tris
buffer for the final range of 7.5-9.25. The standard pNP-Ac assay conditions outlined in Section
4.3.1., was performed with the exception of 3 µM purified WssI. The data is presented as percent
activity of WssI across the various pH values, which was corrected by calculated extinction
coefficient values of pNP at each pH obtained from standard curve analysis (see Table 11 in
Appendix).
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4.3.3. Protein Inhibitor and Common Reagents Assays
Based off of predicted bioinformatics data, WssI is hypothesized to have a “classical”
catalytic triad of histidine, aspartate and serine amino acids that is similar to that processed by
other proteases, lipases and esterases69,70. A standard inhibitor assay was performed to determine
if phenylmethanesulfonylfluoride fluoride (PMSF) (a serine protease inhibitor), methane sulfonyl
fluoride (MSF) (an acetylcholine esterase and serine protease inhibitor), EDTA (metal chelator),
E-64 (cysteine protease inhibitor) and pepstatin A (aspartatic protease inhibitor) would elicit any
inhibition of WssI, given the similarity in their catalytic triads and/or that activity is metal
dependent63,69. After testing initial concentrations and incubation periods of PMSF with both
AiWssI-His6 and PfWssI-His6, the assay conditions were finalized with 3 µM of WssI incubated
for either 1-2 or 24 hrs in 1 mM PMSF (but also tested a range between 0-25 mM), 5 mM MSF,
5 mM EDTA, 0.1 mM E-64 or 20 µM pepstatin A in replicates of at least 4. Assays were run
according to the standard assay conditions outlined for this substrate in Section 4.3.1., with the
exception of 6 mM pNP-Ac, and incubating the protein with the test substrate 1 hr prior to
analysis. To test the effects of the absence of DTT and the addition of a cocktail of protease
inhibitors (containing Aprotinin, Bestatin, E-64, Leupeptin, AEBSF and Pepstatin A), trials were
conducted where DTT was removed from all purification and dialysis buffers or the protease
inhibitor tablet was added to the final dialysis buffer. Assessment of remaining activity for the
common inhibitor and reagent assays was initiated by the standard assay conditions after 1 hr
incubation with WssI, followed by the addition of 6mM pNP-Ac. The appropriate controls
containing buffer, substrate and the absence of enzyme were prepared. The data was accessed as
percent residual activity of compared to the WssI controls (i.e., containing no inhibitors).
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4.3.4. Oligosaccharide Acceptor Assays
The activity of WssI was tested in the presence of cellulose to determine the specific
activity with the addition of various lengths of cellulose oligosaccharides. WssI constructs were
assayed against the acetyl acceptors cellobiose, cellotriose, cellotetraose, cellopentaose and
cellohexaose using pNP-Ac as the acetyl donor. The reactions and blanks were done in trials of 8
in a 96 well plate with standard assay conditions, with the addition of 1 mM of the cellulose
oligosaccharide, 3 µM of WssI and 6 mM pNP-Ac to ensure enzyme saturation (final
concentration of 5% (v/v) ethanol). Reactions controls were also performed in trials of 8
containing no WssI and/or no cellulose acceptor. All trials were monitored at 405 nm for 30 min
and data was accessed as specific activity units (as outlined above) for both constructs relative to
each cellulose acceptor at various concentrations of cellulose substrate.
In order to examine WssI specificity for alternative carbohydrate polymers, both WssI
constructs were also assayed against the chitin oligomers (ranging from a two-unit sugar to a 6unit sugar of GlcNAc residues). The assays were performed using 6 mM pNP-Ac (final
concentration of 5% (v/v) ethanol) as the acetyl donor in trials of 4 with the same reaction
conditions as the cellulose oligomer assays (outlined above). Reactions controls were also
performed in trials of 4 containing no WssI and/or no chitin acceptor. All trials were monitored
and analyzed under the same conditions as the cellulose-based assays.
4.3.4.1.

WssF and WssI Assays

Combination assays were performed to quantitively analyze the effects of WssI and WssF
in the presence of an acetyl donor (pNP-Ac) and acetyl acceptor (cellopentaose). These assays
consisted of a series of three different trials. For the first trial, the activity assays (standard
conditions outlined above) were performed to monitor rate changes in the presence of both
enzymes or various combinations thereof (note that esterase and transferase activity by WssF has
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been previously demonstrated in the lab). The quantity of WssF was held constant at 0.1 nmol,
while WssI was varied (0, 0.05, 0.1, 0.25 and 0.5nmol values). The assay conditions were
conducted according to the standard assay conditions outlined in Section 4.3.1., with the
exception of 1 mM cellopentaose and 6 mM pNP-Ac used in the analysis for trends in activity
with increasing quantities of WssI.
The second set of synergy assays were designed to assess acetyltransfer to the cellulose
substrate for the duration of 24 hrs. This trial combined approximately 1: 2.5 molar ratios of
WssF and WssI, with 1 mM of cellopentaose and 6 mM pNP-Ac (final concentration of 5% (v/v)
ethanol) was added as acetyl-donor to initiate the reaction. The reactions were purified with a
CarboGraph SPE column (Grace Davison Discovery Science) at time points 0.5, 1, 3, 6 and 24
hrs.
The last set of trials employed sequential reactions, beginning with WssF and followed
by WssI, to provide further insight into whether the products of the WssF reaction served as a
substrate for WssI. For these trials, WssF for the first sequential reactions consisted of 0.5 nmol
WssF with 1 mM of cellopentaose and 6 mM pNP-Ac (final concentration of 5% (v/v) ethanol).
The acetylated-cellulose polymer was then purified using CarboGraph columns and concentrated
back to the original reaction volume using the LabConco Centrivap Concentrator. The WssFpretreated cellopentaose was then combined with 1.12 nmol of WssI and incubated and purified
as outlined in the first synergistic trial. The appropriate negative controls were prepared during
each attempt. These samples were analyzed for band intensity via TLC to visualise the addition
or removal of the acetyl group on the cellulose polymer by the Wss proteins (See Section 4.4.1.
for TLC protocol).
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4.3.5. Kinetics
The kinetic properties of the esterase reaction performed by WssI was analyzed with
Michaelis Menten parameters. The kinetic assay was performed in quadruplicate with 50 mM
sodium phosphate buffer (pH 7), 3 µM WssI and a range of concentrations of acetyl donor pNPAc (0-10 mM). The assay was quantified for absorbance readings at 405 nm for 30 min. Kinetic
parameters such as KM and kcat, values were calculated using Graph Pad Prism from the kinetic
curves according to a non-linear regression analysis.
4.3.6. Avicel Binding Assay
To assess that WssI may bind to cellulose, an avicel binding assay (or pull down assay)
was performed combined with SDS-PAGE for detection. Avicel is also known as
microcrystalline amorphous cellulose, which originates from wood or plant fibres71. This form of
cellulose was used to mimic microbial cellulose, with the hypothesis that WssI would be able to
successfully bind to the substrate similar to the in vivo environment. The first trials with avicel
involved varying the concentration of WssI, from 0 µM to 20 µM, while holding the
concentration of avicel (50 µm particle size) constant at 2 mg/mL. DNase was utilized as a
protein control for these trials to demonstrate that avicel binding was specific for WssI. A second
set of trials was also performed where WssI was held constant at 10 µM, while concentrations of
avicel were varied from 0 mg/mL to 6 mg/mL. The assay was performed in 50 mM sodium
phosphate buffer (pH 7) at 22 ℃ for 24 hrs. The reactions were then subjected to centrifugation
at 21,100 xg for 3 min; thereby separating the avicel pellet from the supernatant. The supernatant
sample was saved and combined with 5X SDS sample buffer at a ratio of 2.5: 1 (sample to
buffer). The avicel pellet was washed with 50mM sodium phosphate buffer and subjected to
centrifugation under the same condition. The buffer portion of the separated sample was saved as
fraction “wash 1” and was subjected to SDS sample buffer. The process repeated up to four
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times. The final pellet was then suspended in 5X SDS sample buffer and all samples were heated
for 5 min at approximately 85 ℃. The supernatant and various wash samples were analyzed by
SDS-PAGE according to the protocol outlined above.
4.3.7. Transferase Assay with Donor Acetyl-CoA
The substrate acetyl-CoA had previously been hypothesized to be the biological acetyl
donor substrate in vivo due to previous studies of peptidoglycan O-acetyltransferases located in
the periplasm, similarly to WssI41. This hypothesis was tested utilizing qualitative analysis of a
reaction with Liquid Chromatography coupled with Mass Spectrometry (LC-MS). Reactions
consisted of 50 mM sodium phosphate buffer (pH 7), 3 µM of WssI (reactions were made for
each AiWssI, PfWssI), 1 mM cellopentaose and 4 mM acetyl-CoA. The reaction time was
approximately 20-24 hrs, followed by termination of the reaction by flash freezing the samples at
-20 ℃. These reactions were sent to the Advanced Analysis Centre at the University of Guelph
and subjected LC-MS with positive ion polarity using the Agilent 1200 HPLC, using a C18
column (Agilent Extend-C18 50 mm x 2.1 mm 1.8 µm) for chromatic separation using formic
acid and acetonitrile as solvents at a flow rate of 0.4 mL/min. The mass spectrometer used was
the Agilent LC-UHD Q-Tof by Dr. Dyanne Brewer. Peaks from the LC chromatograms were
each analyzed for the presence of a cellopentaose peak (828 Da) with positive ions and/or an
acetyl adduct (42 Da derivatives), in addition to a potential acetyl-CoA (809 Da) peak and a CoA
peak (767 Da).

4.4. Qualitative Analysis of O-Acetyltransferase Reaction
4.4.1. Thin Layer Chromatography
Thin layer chromatography (TLC) was performed as a means to monitor transfer of an
acetyl group to various oligomers (cellulose or chitin). By a similar protocol outlined by
Sychantha and coworkers, the reaction product was purified using CarboGraph Columns charged
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with 1 column volume (CV) of 100% (v/v) acetonitrile and equilibrated with 2 CVs of water.
After sample adsorption into the graphite carbon filter, the columns were washed with 2 CVs of
water and 1 CV of 50% (v/v) followed by 100% (v/v) acetonitrile to elute the product. The
elution product contains the cellulose or chitin polymer, which would be unmodified (negative
control) or potentially containing polar acetyl groups on the saccharide units (i.e., indication of a
successful transferase reaction). These purified samples were applied and separated using thin
layer chromatography using a protocol adapted from David Sychantha (University of Guelph). A
10 x10 cm aluminum-backed silica TLC plate was spotted with samples using precision capillary
tubes (0.4 mm x 75 mm). The cellulose samples were separating using the mobile phase of ethyl
acetate, water and methanol (6: 3: 6 v/v) using a rectangular developing chamber (General
GlassBlowing Company Inc.). Following separation, the plate was air-dried and sprayed using 𝛼
–naphthol staining solution (3% (w/v) 𝛼–naphthol in 25: 3: 2 methanol, sulfuric acid and water).
The chitin samples were separated using an alternative mobile phase that consisted of 2-propanol
and 25% ammonia solution 7: 3 (v/v) and sprayed with a staining solution containing 1% (w/v)
diphenylamine, 2% (v/v) aniline and 85% (v/v) phosphoric acid and 10% (v/v) acetone. For
detection, all plates were heated at approximately 100 ℃ on a hot plate, until development
reached the desired contrast.
4.4.2. Mass Spectrometry
To verify the results from the reactions visualized by TLC, mass spectrometry was
employed as a secondary validation of the O-acetyltransfer pNP-Ac reactions on cellulose
oligomers. Modified cellulose samples and negative controls eluted in 50% (v/v) of acetonitrile
(purified via CarboGraph Columns) were sent to the Advanced Analysis Centre (University of
Guelph). The samples were subjected to Electrospray ionization with positive ion polarity using
the Bruker AmaZon SL mass spectrometer by Dr. Dyanne Brewer. Peaks from the spectras were
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each analyzed for the presence of cellopentaose peak (828 Da) or cellohexaose (990 Da) with
positive ions and/or an acetyl adduct (42 Da derivatives).

4.5. High-throughput Screening
4.5.1. Assays to Determine Storage Conditions
Storage conditions for WssI constructs were determined to ensure protein stability (as
measured through activity) over time. Identification of optimal conditions for the storage of WssI
was of particular importance for high throughput analysis at the SPARC BioCentre High
ThroughPut Screening (HTS) facility, which was to take place over a number of months.
However, these conditions are also pertinent to the rest of the thesis research that required large
amounts of active protein for the many assays performed.
The protocol for HTS optimized with WssI was used to ensure that the enzyme activity
was consistently compatible through the duration of the screening process. WssI was purified
and stored in aliquots at 4 ℃ (without glycerol) and -20 ℃ and -80 ℃ (in 10% (v/v) glycerol as a
cryoprotectant). The 4-MUB-Ac fluorescence assays (as described in Section 4.3.1.) were used
with WssI at 3 µM (from the tested temperature sample) and 0.5 mM of 4-MUB-Ac. The assays
were performed in at least 8 replicates on day 1, 3, 6 and 16 of incubation in a 90 min assay
monitored at 1.1 min intervals (following with an initial orbital shake for 10 s). Assay data was
calculated as Zʹ values with the following formula:
'()*+, '-./,0 1 2+(34 '-./,0)

(1-ABS (3('()*+, 60,7(8,92+(34 60,7(8,))
4.5.2. High Throughput Screens
The high throughput screening assays were done at the SPARC BioCentre at the Hospital
for Sick Children in Toronto (with assistance by Dr. Leanne Wybenga-Groot and Dr. Rodolfo
Gomez). Primary screening assays were done in 384 well fluorescence-compatible plates.
Approximately 200 L of WssI cultures were expressed and purified to obtain 106.5 mg of
49

protein, which was stored at -20 ℃ in assay buffer with 10% (v/v) glycerol until needed. This
protein was used to screen a subset of the Chembridge DIVERset library containing
approximately 17,911 compounds. The assay was performed with 50 mM sodium phosphate
buffer pH 6.5, 3 µM WssI, 20 µM of a test compounds and initiated upon addition of 0.5 mM 4MUB-Ac (final concentration of 5% (v/v) DMSO). The assays were allowed to proceed for
approximately 45 min alongside appropriate negative and positive controls. Fluorescence was
monitored over the course of the reaction with excitation and emission wavelengths of 365 nm
and 450 nm. Secondary screening assays utilized the same assay format from the primary
screening, but compounds were assayed in triplicate. Lead compounds for the secondary screen
were identified as having a Z score ≤ -3 following primary screening. The secondary screen also
included compounds from the primary screen of WssF and the dose response compounds from
peptidoglycan O-acetyltransferase proteins, OatA and PatB, under the same Z score criteria in
their respective assays. Dose response assays of target compounds were then conducted under
the same conditions as the primary screen, with the exception that an array of compound
concentrations (0, 0.5, 1.6, 4.8, 10.1, 20.2, 40.3, 80.2, and 159.1 µM) were tested to determine
IC50 values for each compound.
Following the HTS screening, lead primary, secondary and dose response were further
screened for fluorescence quenching potential of the compound that could interfere with assay
results. These trials were conducted by Dr. Rodolfo Gomez and the SPARC BioCentre. Briefly,
the compounds were assayed at either 10.1 µM, or both 10.1 µM and 50.5 µM to determine if the
compounds could quench the fluorescence of 4-methylumbeliferone; thereby indicative of
potential false positive hits in the enzyme-based assays. All fluorescence readings were
normalized to determine the percentage of inhibition or activation.
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4.5.3. Inhibitor Verification Assays
A finalized subset of compounds was purchased through MolPort and Enamine after
consultation with Dr. Mark Nitz. Compounds that had the greatest potential as inhibitors of
WssI, due to their predicted amenability to medicinal chemistry improvement, low levels of
fluorescence quenching and/or few known structural flaws that could lead to unwanted
reactions/toxicity were considered in the final set. Approximately 12 compounds were chosen as
inhibitors of WssI based on chemical criteria and availability, which were then categorized in
alphabetical order (see Table 2 for corresponding identification number from the Hospital of
Sick Children CDD Vault). These compounds were prepared as DMSO stocks and assayed
against WssI under the same conditions as the primary and secondary screens with 4-MUB-Ac as
the acetyl donor on a Cytation 5 microplate reader, to verify SPARC-BioCentre results at WLU
(performed with assistance by Adam Deruchie-Tan). Each compound was either tested at
concentrations two times the IC50 values (if compound was originally tested for dose response)
or at 100 µM if the compound did not have dose response data (i.e., identified from primary or
secondary screen instead). Controls containing either no compound or no protein were also
assayed, and the no-compound control was used as the standard reference to determine any
inhibition effects of esterase activity.
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Table 2: Final HTS Compounds with Corresponding CDD Vault Identification Number from the
Hospital of Sick Children.
Compound Name

CDD Vault Identification
number
HSC0002596

Compound A

4.5.3.1.

Compound B

HSC0113332

Compound C

HSC0104541

Compound D

HSC0109757

Compound E

HSC0054645

Compound F

HSC0055255

Compound G

HSC0098657

Compound H

HSC0007989

Compound I

HSC0006734

Compound J

HSC0055185

Compound K

HSC0065256

Compound L

HSC0063093

Follow-up Dose Response Assays

After initial inhibition analysis, the compounds that displayed adequate protein inhibition
were further analyzed to determine the IC50 value. This was done in quadruplicate under routine
assay conditions that included 50 mM sodium phosphate buffer (pH 7), 3 µM WssI, 0.5 mM 4MUB-Ac and inhibitor concentrations ranging from 0 µM to 215 µM. Appropriate negative
controls without protein were also assayed in quadruplicate. The assay was analyzed for relative
fluorescence units at 365 and 450 nm over 90 min with a Cytation 5 microplate reader. The dose
response curves were generated from analyzed data in GraphPad Prism to calculate IC50 values,
which was done utilizing the Michaelis-Menten settings of the dose response parameters within
Prism.
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5. Results
5.1. Bioinformatics of WssI
Bioinformatics models of WssI were used to predict functional, stability and structural
characteristics. An in silico investigation was attempted to acquire homology information from
alignment with amino acid sequences by Phyre2 and additional parameters such as molecular
weight, isoelectric point (pI), extinction coefficient, instability index, and percent similarity were
obtained by ProtParam or BLAST (See Table 3). Due to the instability index values provided by
ProtParam, it was predicted that AiWssI would be slightly more disordered compared to PfWssI
because the index provided by ProtParam was 42.82 and 33.01 for AiWssI and PfWssI,
respectively. Although the predicted instability index suggest that AiWssI was unstable, the
proteins were stable in vitro for all functional assays presented in this thesis but may pose
challenges for future structure characterization by crystallography.
Table 3: In silico Analysis of Protein Parameters from ProtParam.
Parameter
Number of Amino Acids
Molecular Weight
Theoretical isoelectric point (pI)
Extinction Coefficient (280nm
assuming all Cys residues form
cystines)
Instability Index (II) (values
above 40 predict instable
proteins)
% Similarity42

AiWssI C-terminal His-tag PfWssI C-terminal His-tag
294
292
31683.64 Da
31476.46 Da
6.20
6.30
-1
-1
50085 M cm
33585 M-1 cm-1

42.82 (identified as
unstable)

33.01 (identified as stable)

62%

A Phyre2 homology model of PfWssI (Figure 9: Panel A) predicted that WssI has
multiple 𝛼-helices of various lengths and 7 𝛽-strands, which is consistent with other esterase and
transferase proteins that have an 𝛼/𝛽/𝛼 fold (See Figures 10 and 11)34. The conserved catalytic
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residues, serine, histidine and aspartate are outlined in magenta representing the catalytic active
site of PfWssI and two cysteine residues (Cys160 and Cys102) hypothesized to form a disulfide
bond are outlined in blue (Figure 9: Panel B and C). Protein homologs from the Phyre 2 output
are summarised in Table 4 with corresponding alignment coverage and percent identity and
similarity values. The alignment coverage for all homologs does not exceeded 73%, implying
that these hypothetical models are useful for only predicting function, and structure of WssI as
the alignment does not cover the whole sequence. The protein that PfWssI has the highest
sequence identity with (29% at the amino acid level) was an esterase/transferase protein involved
in the acetylation of alginate within P. aeruginosa, named AlgJ34,65. In addition, PfWssI has 25%
homology at the amino acid level with the sugar binding /acetyltransferase protein of the alginate
system, AlgX34,65. Although percent identity of these alignments are low, the percent similarity
values range from 47-46%, supporting the predicted function of WssI relative to the alginate
homologs. Analysis from Clustal Omega outputs confirmed sequence alignment, utilizing the Calpha atoms matching system (Figure 40 in Appendix for full sequence alignment). PyMol
structural alignments of WssI and AlgJ in addition to WssI with AlgJ and AlgX are shown in
Figures 10 and 11, respectively. Lastly, PfWssI has 14% identify at the amino acid level with a
peptidoglycan acetyltransferase from Bacillus cereus, PatB140,65. However, due to the low
homology this protein was excluded from the alignment figures.
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Figure 9: Predicted Three-Dimensional Structure of WssI Rendered from Phyre 2 Sequence
Alignment Analysis.
Panel A presents the predicted structure of WssI, modeled on an O-Acetyltransferase domain of
Pseudomonas putida, AlgJ (PDB: 4O8V) using Phyre 2 based on 29% amino acid identity
between the proteins. Panel B shows the orientation of putative catalytic residues Asp 205, His
207 and Ser 304, depicted in magenta. Distances between atoms of active site residues involved
in catalysis are shown by dashed lines. Panel C outlines the predicted location of a disulfide bond
formed by the highlighted cysteine residues, Cys 160 and Cys102 (shown in blue). All figures
rendered in PyMol.
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Table 4: Alignment Parameters from Phyre 2 Analysis of Homologous Proteins of WssI.
Protein Homolog

Confidence*

% ID***

100%
100%

Coverage
(%)**
73%
71%

29%
25%

Similarity
(%)****
47%
46%

AlgJ (esterase/transferase)
AlgX (sugar
binding/transferase)
PatB1 (O-acetyltransferase)

100%

72%

14%

45%

*Prediction of the probability that the proteins are homologs,
**Percentage of sequence alignments that was found between the two sequences
***Percentage identity between the input sequence and the template65.
**** Percentage of similar amino acids (i.e., charge, aromatic, etc) within the aligned
sequence42.

Figure 10: Three-Dimensional Alignment of Predicted Structure of WssI (green) and AlgJ
(PDB: 4O8V) (indigo).
Conserved active site residues serine, histidine and aspartate are depicted in magenta to outline
the active site. Alignment has 73% confidence and 29% amino acid identity output from Phyre 2.
Figure rendered in PyMol.
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* *

*

AlgJ

WssI

AlgX

Figure 11: Three-Dimensional Alignment of Predicted Structure of WssI (green) and AlgJ
(PDB: 4O8V) (indigo) and P. aeruginosa acetyltransferase, AlgX (PBD: 4KNC) (yellow).
The alignment outlines significant conserved active site residues serine, histidine and aspartate
are depicted in magenta to outline the active site, in addition to neighbouring residues.
Alignment has 73% confidence and 29% amino acid identity with AlgJ and 72% coverage and
25% amino acid identity with AlgX output from Phyre 2. Figure rendered in PyMol and
Alignment from Clustal Omega output in JalView.

5.2. Protein Expression and Purification
Plasmid constructs were routinely obtained at approximate yields of 66 ng/µL for the
PfWssI construct (midiprep) and 22 ng/µL for the AiWssI construct (miniprep). Both AiWssI and
PfWssI were successfully expressed in E. coli BL21 Rosetta codon plus cells following induction
for 18-24 hrs (T=ON lanes possessing bands indicated with an arrow in Figure 12). The
purification of both constructs were relatively similar, as represented by SDS-PAGE analysis of
each IMAC purification step, that are depicted in Figures 13 and 14, Panels A and B. The
recombinant WssI proteins began eluting from the HisTrap FF Ni-NTA column in the first peak
from the chromatogram, with the majority of WssI eluting in the second peak (See Figure 15 for
chromatogram). At 175 mM imidazole concentration WssI eluted with a ~25 kDa E. coli
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chaperon, SlyD (confirmed through gel extraction and mass spectrometry sequencing). By
comparing the IMAC purification to the anion exchange purifications (Figures 13 and 14: Panel
A, Lanes 2-5 and 6-10, respectively) the SlyD protein eluted from the anion exchange column at
a salt concentration of 450 mM in Peak 4 for AiWssI (Figure 13: Panel A, Lane 10) and in the
flow through and wash fractions for the PfWssI purification (Figure 14: Panel A, Lanes 7 and 8).
The presence of C-terminal His6-tagged protein WssI was followed throughout the purification
process using Western blot analysis (Figures 13 and 14B). The Western blot analysis of AiWssI
(Figure 13B) revealed degradation of the protein throughout the purification process evident
from the presence of multiple bands on the blot. The higher MW band was purified in later
elutions of anion exchange (Figure 13B Lanes 9 and 10). A total protein yield after IMAC
purification was typically 0.8 mg and 1.5 mg from 1L cultures, for the AiWssI and PfWssI
constructs, respectively. In comparison, the yield after anion exchange purification was 0.125 mg
and 0.25 mg for AiWssI and PfWssI from 1 L cultures of each.

Lane: 1

AiWssI
T=0 T=ON
2
3

4

PfWssI
T=0 T=ON
5
6

kDa
75
50
37
25
20

Figure 12: SDS- PAGE Protein Expression of AiWssI and PfWssI.
SDS-PAGE analysis of AiWssI and PfWssI of 1 L cultures incubated at 17 ℃. Lane 1, molecular
mass marker (kDa), Lane 2 and 5, time zero (T=0) prior to IPTG induction and Lanes 3 and 6,
post expression (T=ON), after 16-18 hrs. The arrows indicate the predicted molecular mass and
presence of the WssI proteins.
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Figure 13: SDS-PAGE and Western Blot Analysis of AiWssI Purification.
A) Lane 1 contains the molecular mass marker (kDa); Lane 2, the lysate that was passed through
the HisTrap column; Lane 3, unbound proteins that were washed off the column (concentrations
less than 50 mM of imidazole); Lane 4 the first elution peak from the column (50 mM
imidazole), and Lane 5, the second elution peak from the column (175 mM imidazole). Lane 6,
Flow through of protein sample that was passed through the anion column; Lanes 7, elution 1
(150 mM NaCl); Lane 8, elution 2 (225 mM NaCl); Lane 9, elution 3 (350 mM NaCl); and Lane
10, elution 4 (450 mM NaCl). B) Western blot analysis of AiWssI purification profile, replicated
from SDS-PAGE gel with the exception of the removal of the IMAC wash fraction.
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Figure 14: SDS-PAGE and Western Blot Analysis of PfWssI Purification.
A) Lane 1 contains the molecular mass marker (kDa); Lane 2, the lysate that was passed through
the HisTrap column; Lane 3, unbound proteins that were washed off the column; Lane 4 the first
elution peak from the column (50 mM imidazole), and Lane 5, the second elution peak from the
column (175 mM imidazole). Lane 7, Flow through of protein sample that was passed through
the anion column; Lanes 8, unbound protein washed off the column (125 mM NaCl); Lane 9,
elution of PfWssI (200 mM NaCl). B) Western blot analysis of PfWssI purification profile,
replicated from SDS-PAGE gel.
(A)

Wash

Peak 1

(B)

Wash

Peak 1

Peak 2

Figure 15: Representative Chromatogram of WssI Purification on IMAC Column and Anion
Exchange Column.
A) IMAC Peak 1 represents the first elution at 50 mM imidazole, Peak 2 represent the second
elution containing the majority of purified WssI, eluting with 175 mM imidazole. B) Anion
Exchange Peak contains the majority of the pure protein eluting with 200 mM of NaCl.
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5.2.1. Protein Expression and Purification of WssI Site Directed Mutants
As previously mentioned in the bioinformatics Section 5.1., aspartate, histidine and serine
were identified as the active site residues based on alignment to homologous proteins. Each
active site residue from genes encoding AiWssI (D209, H211 and S309) and PfWssI (D205,
H207 and S304) were mutated to alanine. In total, 6-point mutations were attempted through site
directed mutagenesis. The generation of AiWssIS309A and AiWssIH211A were performed with a
primer annealing temperature of 55 ℃, and PfWssIS304A using touch down PCR from 68-52 ℃
with the addition of 4% (v/v) DMSO to the reaction mixture. By using TCAG sequencing server
(Hospital for Sick Children), the sequence changes for these were verified. Each mutant
construct was also successfully transformed into E. coli Rosetta codon plus BL21 cells, which
were then used to produce protein that was later purified.
The proteins were expressed and purified using the same protocols as the AiWssI and
PfWssI WT constructs. All mutant constructs were expressed in E. coli BL21 Rosetta codon plus
cells following induction by IPTG for 18-24 hrs (T=ON), which can be compared to cell growth
prior to induction (T=0), by the absence and presence of WssI at 32 kDa (Figures 16 and 17:
Lanes 2 and 3) The IMAC and anion exchange purified samples of AiWssIH211A and AiWssIS309A
had increased in purity confirmed by the reduction of contaminant bands as judged by SDSPAGE analysis (Figure 16: Panel A, comparing both “Peak 2” samples; Panel B comparing
“Peak 2” and” Peak” samples for IMAC and anion exchange, respectively), The recombinant
proteins began to elute from the IMAC column at concentrations of 125 mM and 50 mM
imidazole leading up to 175 mM for complete elution for AiWssIH211A and AiWssIS309A,
respectively (Figure 16: IMAC Peak 1 and 2 samples). Anion exchange improved the overall
purity of the constructs, eluting AiWssIH211A in a gradient of 150 mM to 275 mM NaCl (Figure
16: Panel A, Lanes 9 and 10), and AiWssIS309A eluting from the anion column at 150 mM NaCl
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(Figure 16: Panel B, Lane 10). Approximately 0.06 mg/L of culture for AiWssIH211A and 0.09
mg/L of culture for AiWssIS309A were obtained after purification. The PfWssIS304A exhibited the
best expression and purification, as compared across all constructs in Figure 17. This construct
began to elute from the IMAC column at 125 mM imidazole (Figure 17: Lane 6) and 175 mM
imidazole (Figure 17: Lane 7), and 200 mM NaCl was required to elute PfWssIS304A from the
anion exchange column (Figure 17: Lane 10). The mutant construct had the highest purity (with
very few contaminant bands as judged from the SDS-PAGE gel Figure 17) with a yield of 0.065
mg/L of culture. The presence of double banding can be seen in flow through, wash and peak
samples of the anion exchange of all constructs (Figures 16 and 17: Lanes 7/8-10). This double
banding could be due to slight degradation throughout the purification process. These three
proteins with select gene mutations were analyzed for esterase and transferase activity relative to
the wild type enzymes.
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Figure 16: SDS-PAGE of Expression, IMAC and Anion Exchange Purification of AiWssI
mutants.
Panel A) Expression and purification profile of AiWssIH211A; Panel B) expression and
purification profile of AiWssIS309A. Lane 1, molecular mass marker (kDa); Lane 2, time zero
(T=0) prior to IPTG induction; Lane 3, post expression (T=ON), after 16-18 hrs; Lane 4, the
lysate that was passed through the HisTrap column; Lane 5 (Panel B), unbound proteins that
were washed off the column (concentrations less than 50 mM of imidazole); Lane 5/6 the first
elution peak from the column (50-125 mM imidazole), and Lane 6/7, the second elution peak
from the column (175 mM imidazole). Lane 7/8, Flow through of protein sample that was passed
through the anion column; Lanes 8/9, unbound proteins that were washed off the column; Lane
9/10, elution (150 mM NaCl); Lane 10 (Panel B), elution 2 (275 mM NaCl).
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Figure 17: SDS-PAGE of Expression, IMAC, Anion Exchange Purification of PfWssIS304A.
Lane 1, molecular mass marker (kDa); Lane 2, time zero (T=0) prior to IPTG induction; Lane 3,
post expression (T=ON), after 16-18 hrs; Lane 4, the lysate that was passed through the HisTrap
column; Lane 5, unbound proteins that were washed off the column (concentrations less than 50
mM of imidazole); Lane 6 the first elution peak from the column (120 mM imidazole), and Lane
7, the second elution peak from the column (175 mM imidazole). Lane 8, Flow through of
protein sample that was passed through the anion column; Lanes 9, unbound proteins that were
washed off the column; Lane 10, elution (200 mM NaCl).

5.3. Determining WssI Specificity
5.3.1. Esterase Activity of WssI
The esterase activity of WssI was examined through a routine esterase assay using
increasing concentrations of WssI while the concentration of the acetyl donor, pNP-Ac, was held
constant. This assay was designed to ensure that the activity of WssI utilizing pNP-Ac could be
measured consistently through the colourimetric assay and was dependent on enzyme
concentration. Higher quantities of WssI resulted in increased cleavage of the ester bond; thereby
confirming that the results observed were enzyme dependent (Figure 18: Panel A). This assay
was also used to verify an increased rate of reaction using fluorescence-based acetyl-donor, 4methylumbliferyl acetate (4-MUB-Ac) over time (Figure 18: Panel B). With knowledge that
WssI exhibits esterase activity by both commercial substrates (pNP-Ac and 4-MUB-Ac), the
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standard assay was used later for functional assays, site directed mutant activity analysis and
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Figure 18: Rate of Reaction with Increasing Concentrations of WssI and Specific Activity with
Acetyl Donors pNP-Ac and 4-MUB-Ac .
Panel A) Reaction conditions performed in quadruplicate included 50mM sodium phosphate
buffer pH 7, 0-15 µM AiWssI and 2 mM pNP-Ac. The pNP-Ac based assay shows an increasing
slope indicating that the reaction is dependent on WssI concentration. Panel B) Reaction
conditions performed in quadruplicate included 50 mM sodium phosphate buffer pH 7, 3 µM
AiWssI and 0.5 mM 4-MUB-Ac. This fluorescence based assay shows an increasing specific
activity (µmol • min-1 • mg-1) over time.
5.3.2. pH Profiles
An analysis of the effects of pH on WssI activity was conducted for both A. insuavis and
P. fluorescens WssI proteins to compare the two proteins and characterize the optimal pH for
activity. The profiles of both constructs are depicted in Figure 19 and, as expected, are similar
for the two proteins. Low activity was detected at the lower pH ranges (MES buffer), which
steadily increased in activity from pH 7 to 8.5 in both the sodium phosphate and Tris buffers.
The trials in the higher pH buffer exhibited high activity with short reaction times (i.e., the
reaction rate was faster), even after the auto-hydrolysis of pNP-Ac that occurs with ester bonds at
higher pH values, which was accounted for through blank subtraction. Overall, both AiWssI and
PfWssI had the highest activity in Tris buffer pH 8.5, which confirms that the activity of the
WssI protein is dependent upon buffer type and/or pH.

65

Figure 19: Analysis of pH Profiles of WssI.
AiWssI is represented by the circle line and PfWssI by the square line. Protein was assayed in 50
mM MES buffer for pH 5.5-6.5, 50 mM sodium phosphate buffer for pH 6.5-7.5 and 50 mM Tris
buffer for pH 7.5-9.25. The assays were performed in trials of 8.
5.3.3. Effects of Common Inhibitors and Stabilizing Agents
The inhibitors of interest such as PMSF and MSF were assayed with WssI to determine if
the serine protease inhibitor and acetylcholine/serine esterase inhibitor could inhibit the activity
of WssI by irreversibly binding to the active site serine. Due to precipitation of PMSF at high
concentrations, concentrations of 1mM and lower of PMSF were tested to determine if WssI
would be successfully inhibited by PMSF after 1 hr or 24 hr incubation (Figure 20: Panel A and
B, respectively). However, no inhibition of WssI was detected after even extensive incubations
(Figure 20 and Table 5). As a follow up step, WssI was also tested for inhibition by MSF. In
comparison to PMSF, MSF is a smaller chemical without the additional phenyl group. Samples
of WssI were treated with 5mM MSF for 1 hr prior to analysis, but no detectible inhibition in
activity was noted (Table 5). Neither PMSF or MSF were deemed catalytic inhibitors of WssI.
Due to the unsuccessful inhibition or compatibility of the serine protease inhibitors PMSF and
MSF, two additional protease inhibitors were chosen to further assess the proposed catalytic
aspartate (by Pepstatin A) and the importance of the two cysteine residues (by E-64) of WssI.
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The results revealed that both protease inhibitors did not effectively inhibit WssI due increases in
activity shown in Table 5.

Effects of PMSF After 1-hour Incubation
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Figure 20: Effects of PMSF on WssI Enzyme Activity Following Various Incubation Periods.
Inhibition of AiWssI (circle line) and PfWssI (square line) in 50 mM sodium phosphate buffer
pH 7, containing either 0, 0.5 and 1 mM PMSF, 3 µM WssI and 2 mM pNP-Ac. Panel A) 1 hr
incubation of WssI with PMSF resulting in no loss in activity, Panel B) 24 hr incubation of WssI
with PMSF resulting in inconclusive loss of activity. All trials consisted of replicates of 8 for
each data point.
Interestingly, incubation of WssI with a protease inhibitor cocktail (used initially in the
research during purification) dramatically decreased the esterase activity of WssI to 2.2 +/- 0.3%
residual activity (Table 5). However, our systematic assessment of some of those inhibitors in
this cocktail (outlined above) did not reveal the same level of inhibition. Regardless, purification
of WssI was routinely performed in the absence of protease inhibitors to prevent any unwanted
inhibition.
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Table 5: Summary of Remaining Activity of WssI After Exposure to Common Inhibitors
and Reagents.
Reagent

Residual Activity (%)*
PfWssI

AiWssI

1mM PMSF

98.8 +/- 3.6

101.4+/- 4.4

5mM MSF

112.1 +/- 4.4

95.0 +/- 6.2

5mM EDTA

88.5 +/- 1.3

91.9 +/- 1.4

No DTT

10.65 +/- 5.60

-

Protease inhibitors

2.2 +/- 0.3

-

0.1mM E-64

108.3 +/- 10.9

-

20µM Pepstatin A
99.2 +/- 6.1
* WssI was incubated for 1 hr with each listed inhibitor in standard assay conditions prior to the
assay being initiated with the addition of 6 mM pNP-Ac.
To further study functional characteristics of WssI, other additives were tested against the
enzyme. Prior to the initiation of standard assay conditions, WssI was incubated for 1 hr with 5
mM EDTA, and results determined that there was approximate 90% remaining activity (See
Table 5); thereby supporting that WssI is not a metalloenzyme. Lastly, effects of having DTT
through the purification process of WssI were also analyzed for its possible effect on activity.
The removal of DTT from the purification and dialysis buffers established a decrease in activity
by approximately 90% (10.65 +/- 5.60% residual activity) (See Table 5).
5.3.4. Kinetics
The kinetic parameters of WssI were established including the Michaelis-Menten
constant, turn over numbers and catalytic efficiency of both protein constructs. The esterase
reaction of WssI was saturated at acetyl donor concentrations exceeding 5 mM of pNP-Ac
(outlined in the Michaelis-Menten curves of Figure 21). Kinetic parameters from tabulated
Michaelis-Menten curves indicated that both PfWssI and AiWssI were found to have similar KM
values of 2.48 +/- 0.91 mM and 2.31 +/- 0.43 mM, respectively (See Table 6). The kcat values
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also showed that PfWssI can turn over slightly more substrate in a period of time (7.99 x10-3 +/9.98 x10-4 s-1) compared to AiWssI (kcat of 4.05 x10-3 +/- 2.46 x10-4 s-1). Lastly, the catalytic
efficiency parameter (kcat /KM) confirmed the trend in which PfWssI was more catalytically
efficient with a constant of 3.23 M -1·s-1 that was close to double the catalytic efficiency
ofAiWssI of 1.77 x101 M -1·s-1 (See Table 6).

Enzyme Activity (mM/sec)
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AiWssI
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1.5´ 10 -5
1´ 10 -5
5´ 10 -6
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Figure 21: Michaelis-Menten Kinetic Curves of AiWssI (circles) and PfWssI (squares) Esterase
Reactions.
Assays were performed in quadruplicate in 50 mM sodium phosphate buffer (pH 7.0), 3 µM
WssI and 0-10 mM pNP-Ac. The assay was quantitatively assessed at 405 nm for 30 min.
Table 6: Kinetic parameters of PfWssI and AiWssI.
Construct
KM (mM)
kcat (s-1)
kcat/KM (M -1·s-1)
PfWssI
2.48 +/- 0.91
7.99 x10-3 +/- 9.98 x10-4
3.23
-3
-4
AiWssI
2.31 +/- 0.43
4.05 x10 +/- 2.46 x10
1.77
* Kinetic parameters were calculated using the Michaelis-Menten program from GraphPad nonlinear regression one-binding site model.
5.3.5. Oligosaccharide Acceptor Activity
Performing the WssI activity assay in the presence of cellulose as a substrate acceptor
was hypothesized to lead to an increase in specific activity that may be dependent on the length
of the cellulose acceptor used. The theory was that the cellulose acceptor would mimic the
biological acceptor and allow for increased turnover of the enzyme. At the outset of these
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experiments, care was taken to ensure the donor (assayed at 2 mM, 4 mM and 6 mM pNP-Ac)
was not a limiting factor of the reaction and that any rate changes would be due to the specificity
for acceptors (note that in subsequent kinetic trials, 6 mM is above the KM for both enzyme
variants). As noted in Table 7, specific activity values with 6 mM pNP-Ac as a donor did not
lead to any significant increase in rate that was dependent on cellulose acceptor length for the
PfWssI construct. While the specific activity of PfWssI in the presence of cellotriose and
cellotetraose was statistically different from the no-acceptor controls (Table 7), it was a slight
decrease in activity that was noted and not an increase. In contrast, specific activity assays with
AiWssI (Table 8), suggested that the specificity of this construct of WssI for cellulose oligomers
did increase slightly with the length of the polymer. The student t-test revealed that the reported
specific activity values were statistically significant for all AiWssI samples with the exception of
cellotriose, but the magnitude of the changes was still relatively small. An additional finding
from these assays is that AiWssI had a slightly lower specific activity across all assays when
compared to the PfWssI construct (visually represented a bar graph presented in Figures 22:
Panel A), which is consistent with the kinetic parameters described above.
Table 7: Specific Activity of PfWssI Monitored in the Presence of Various Cellulose
Acceptors.*
Acceptor

PfWssI Specific Activity PfWssI Specific Activity PfWssI Specific Activity
2 mM pNP-Ac (µmol •
4 mM pNP-Ac (µmol •
6 mM pNP-Ac (µmol •
-1
-1
-1
-1
min • mg )
min • mg )
min-1 • mg-1)
No acceptor
0.641 +/- 0.029
1.10 +/- 0.067
1.41 +/- 0.12
Cellobiose
0.699 +/- 0.024
1.15 +/- 0.17
1.39 +/- 0.04
Cellotriose
0.591 +/- 0.579
1.12 +/- 0.16**
Cellotetraose
0.855 +/- 0.023
1.27 +/- 0.10**
Cellopentaose
1.30 +/- 0.13
Cellohexaose
1.39 +/- 0.04
* All assays were performed in at least quadruplicate in 50 mM sodium phosphate buffer (pH 7),
1 mM cello-oligosaccharide, 3 µM PfWssI and 2-6 mM pNP-Ac.
**p < 0.05 and therefore statistically significant.
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Table 8: Specific Activity of AiWssI Monitored in the Presence of Various Cellulose
Acceptors.*
Acceptor

AiWssI Specific Activity 2
AiWssI Specific Activity
mM pNP-Ac (µmol • min-1 •
6 mM pNP-Ac (µmol • min-1 •
mg-1)
mg-1)
No acceptor
0.460 +/- 0.002
0.750 +/- 0.076
Cellobiose
0.434 +/- 0.008
0.876 +/- 0.066**
Cellotriose
0.417 +/- 0.024
0.817 +/- 0.042
Cellotetraose
0.435 +/- 0.008
0.881 +/- 0.059**
Cellopentaose
0.959 +/- 0.069**
Cellohexaose
0.984 +/- 0.064**
* All assays were performed in at least quadruplicate in 50mM sodium phosphate buffer (pH 7),
1 mM cello-oligosaccharide, 3 µM AiWssI and 2 and 6 mM pNP-Ac.
**p < 0.05 and therefore statistically significant.

1.50

*

1.25
1.00

*

*

PfWssI

*

*

*

AiWssI

0.75
0.50
0.25

A
cc
ep
to
r
C
el
lo
bi
os
e
C
el
lo
tr
io
C
se
el
lo
te
tr
ao
C
el
se
lo
pe
nt
ao
C
se
el
lo
he
xa
os
e

0.00

PfWssI

1.75
1.50
1.25
1.00

*

*

AiWssI

0.75
0.50
0.25
0.00

N
o

A
cc
ep
to
C
r
hi
to
bi
os
e
C
hi
to
tr
io
C
se
hi
to
te
tr
ao
C
hi
se
to
pe
nt
ao
C
se
hi
to
he
xa
os
e

1.75

Specific Activity (mmol/min/mg)

(B)

N
o

Specific Activity (mmol/min/mg)

(A)

Figure 22: Specific activity (µmol • min-1 • mg-1) of PfWssI and AiWssI Monitored in the
Presence of Cellulose Oligomers and Chitin Oligomer Acceptors.
Sizes of a two-unit sugar to a six-unit sugar were used to characterize the specific activity of both
proteins. Assays were performed in trials of 8 in 50 mM sodium phosphate buffer (pH 7), 1 mM
oligosaccharide (Panel A-Cellulose and Panel B-Chitin), 3 µM WssI and 6 mM pNP-Ac as the
acetyl donor. p < 0.05 for samples indicated by the asterisk, which were therefore statistically
significant.
To determine whether the cellulose-acceptor results with WssI were specific for this
enzyme, chitin oligomers (analogous to cellulose, but contain an N-acetyl group at position 2 of
the sugar ring) were also assayed under the same conditions as an alternative acetyl-acceptor.
The trends in specific activity of WssI in the presence of chitin oligomers are shown in Figure 22
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(Panel B). Similar to the results with cellulose acceptors with the PfWssI construct, chitobiose
and chitotetraose as acceptors lead to a slight decrease in activity, but all other reactions
(including those with AiWssI) lead to rejection of the null hypothesis using a student t-test.
Overall, the results from these combined cellulose and chitin acceptor-based assays indicate that
there is either no trend or only slight increases in activity linked to polymer length. Thus, the use
of the esterase activity assay as an indicator of acetyltransfer by WssI constructs with cellulose
oligomers was elusive under the assay conditions tested. Additional reactions assayed with TLC
and MS were employed instead (outlined in Section 5.4) to better assess the precise requirements
of WssI for acceptors.
5.3.5.1.

Enzymatic Analysis of Mutants

The purified mutants were assayed for esterase and transferase activity utilizing pNP-Ac
or 4-MUB-Ac as the acetyl donor and cellopentaose as the acetyl acceptor in the transferase
reaction. The activity of AiWssIH211A and AiWssIS309A with pNP-Ac as the acetyl donor was 67.2
+/- 5.7% and 78.5 +/- 2.6% relative to the WT, respectively. With 4-MUB-Ac as the acetyl
donor, the remaining esterase activity of AiWssIH211A was lower (47.9 +/-3.55%), but
AiWssIS309A was consistent between the two substrates tested (Table 9). In the presence of the
cello-acceptor, transferase activity of AiWssIH211A decreased to 45.5 +/- 2.8% remaining activity,
but the activity of AiWssIS309A was similar to the WT construct, at 85.9 +/- 5.9% activity
(approximately 14% lower than in the absence of acceptor).
The PfWssI wild type and PfWssIS304A were assessed using the same esterase and
transferase assays as the AiWssI wild type and gene mutants. The reduction in activity for the
serine mutant was similar between AiWssI and PfWssI enzyme variants using pNP-Ac as the
acetyl-donor, with 80.5 +/- 0.6% and 81.9 +/- 6.4% remaining activity for the esterase and
transferase activity for PfWssIS304A (Table 9). The residual esterase activity of PfWssIS304A with
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4-MUB-Ac was also reduced (60.6 +/- 3.1% residual activity) compared to the wild type
enzyme, but unlike AiWssI, the transferase activity did not increase with the donor substrate in
the presence of cello-acceptor (59.1 +/- 2.3% transferase remaining activity) (Table 9). All data
from Table 9 was graphically represented in Figures 37 and 38 of the Appendix.
Table 9: Summary of Overall Residual Esterase and Transferase Activity of WssI WT and
Mutant Proteins using pNP-Ac or 4-MUB-Ac as the Acetyl Donor.

Protein
AiWssI WT

Residual Activity with pNP-Ac as
Acetyl Donor (%)*
Esterase Activity
Transferase
Activity**
100 +/- 7%
113 +/- 7.5%

Residual Activity with 4-MUB-Ac as
Acetyl Donor (%)*
Esterase Activity
Transferase
Activity**
100 +/- 2.5%
85.9 +/- 5.9%***

AiWssIH211A

67.2 +/- 5.7%***

75.3 +/- 0.4%***

47.9 +/- 3.6%***

45.5 +/- 2.8%***

AiWssIS309A

78.5 +/- 2.6%***

95.2 +/- 4.9%

77.9 +/- 12.5%

85.9 +/- 7.8 %

PfWssI WT

100 +/- 3.5%

103 +/- 7%

100 +/- 4%

98.9 +/- 5.9%

PfWssIS304A

80.5 +/- 0.6%***

81.9 +/- 6.4 %***

60.6 +/- 3.1 %***

59.1 +/- 2.3%***

* All residual activity is related to the WssI WT esterase reaction for each organism’s set of
enzymes.
Transferase activity is also referred to as esterase activity in the presence of cellopentaose.
***p < 0.05 and therefore represents a statistically significant reduction in activity compared to
each WT.
5.3.6. Avicel Binding Assays
The avicel binding assay was employed as a crude test to determine if PfWssI’s affinity
for cellulose in the long polymer/globular form, which would mimic the structural properties of
microbial cellulose for binding. The first trial of this analysis tested the binding of various
concentrations of WssI in the presence of 2 mg/mL of avicel. The absence of protein in the
negative control series (Figure 23: Panel A, 0µM WssI) ensured that there was no contamination
in our experimental set up. The absence of binding within the DNase control (Figure 23: Panel C,
DNase) further provided confidence that non-specific binding to cellulose was accounted for
through our washing steps. For the WssI treated samples (Figure 23: Panel A, Supernatant), the
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presence of protein in the supernatant samples indicated not all the protein was able to bind to
the avicel under the conditions tested. Following removal of the supernatant and washing of the
pellet some of the bound protein was removed (Figure 23: Panels A-C, Washes 1 and 2).
However, even after the extensive washing process, some WssI remained bound to the avicel
pellet and was only liberated for analysis following denaturation in SDS-PAGE buffer and
heating at 100 ℃ (Figure 23: Panels A-C, Pellet). These results provide qualitative evidence that
WssI has at least weak binding affinity for this polymer of cellulose. Of note are the double
banding patterns in some of the pellet samples, which correlated with patterns carried over from
the purification process, or due to extensive incubations (approximately 24 hrs), resulting in
degradation that occurs with this protein over time at 22 ℃.
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Figure 23: SDS-PAGE Gels Representing the Avicel Binding Assay with Varying PfWssI
Concentrations.
Assay conditions incubations of 24 hrs in 50 mM sodium phosphate buffer pH 7.0, 2 mg/mL
avicel and WssI in concentrations as indicated. Panels A-C) Lane 1 contains molecular mass
ladder; Lanes 2 and 7 depict the supernatant; Lanes 3, 4 and 8, 9 contain washes; and Lanes 5
and 10 is the pelleted sample. Panel A) Lanes 2-5 showing the negative control with no WssI,
and lanes 7-10 show the sample containing 5 µM of WssI. Panel B) Lanes 2-5 depict avicel
binding samples resembling 10 µM of WssI, and lanes 7-10 show the sample containing 15 µM
of WssI and avicel. Panel C) Lanes 2-5 contain 20 µM WssI and avicel, and lanes 7-10 show the
control containing 0.125 mg/mL DNase. These trials are representative of individual trials of this
assay.
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To further explore the specificity of WssI binding to avicel, a second trial was
implemented where the concentration of WssI was held constant at 10 µM and the avicel
concentrations were varied. Similar to the initial assay, the majority of the protein remained in
the supernatant fraction and only small quantities of WssI were present in the avicel pellets
(Figure 24: Panels A-C). However, the band intensities of the protein bound to avicel pellet
samples (Figure 24: Panels A-C, pellet samples) do appear to intensify slightly with increasing
avicel concentration, which was proven by relative intensity values graphed in Figure 39 in
Appendix. These findings are confounded by the presence of WssI in the negative control pellet
(Figure 24: Panel A, Pellet), where it was observed that throughout these trials WssI precipitated
from solution and remained through the washing and pelleting step. However, at the 2-6 mg/mL
concentrations, the level of protein is clearly above the intensity of this background binding and
provides further verification that WssI can bind to this polymer.
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Figure 24: SDS-PAGE Gels of the Binding of PfWssI to Varying Avicel Concentrations.
Assay conditions incubations of 24 hrs in 50 mM sodium phosphate buffer pH 7.0, 10 µM WssI
and avicel in concentrations as indicated. Panels A-C) Lane 1 contains molecular mass ladder;
Lanes 2 and 7 depict the supernatant; Lanes 3,4 and 8, 9 contain washes; and Lanes 5 and 10 is
the pelleted sample. Panel A) Lanes 2-5 showing the negative control with avicel, and lanes 7-10
show the sample containing 0.5 mg/mL avicel. Panel B) Lanes 2-5 depict avicel binding samples
resembling 1 mg/mL avicel, and lanes 7-10 show the sample containing 2 mg/mL avicel. Panel
C) Lanes 2-5 contain 4 mg/mL avicel, and lanes 7-10 show the samples with 6 mg/mL avicel.
These trials are representative of individual trials of this assay.
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5.3.7. WssI and WssF Combination Assay
Combinatorial assays were conducted to determine trends in activity between WssI and
WssF (a partner acetyltransferase in the Wss system). These assays specifically determine the
enhanced activity in the presence of both proteins, later tested for acetylation profiles of the
cellulose acceptor substrates. In the first trial, the transferase activity was used as a measure of
synergy and WssI concentrations varied while WssF was held constant. As evidenced by Figure
25, a difference between the trials was not detected as the concentration of WssI was increased
(i.e., no p-values above the standard ((𝛼=0.05)). Although the reaction did not reveal synergy,
similar reactions under altered assay conditions were used to assess if acetyltransfer may have

0.0015

0.0010

0.0005

I

I
W

W

ss

ss

I

ol
nm
5

25
0.

0.

nm

ol
nm
1
0.

nm
5
0.

07

ol

W

W
ol

W
ol

05
0.

ss

ss

I
ss

I
ss
nm

ol
nm
0

I

0.0000
W

Rate of pNP Release (µmol/min)

been affected (Section 5.4.)

Additions of WssI to 0.1 nmol WssF

Figure 25: Monitored Rate of pNP released (µmol/min) by Combination Effects of WssI and
WssF.
Assays were performed in trials of 6 in 50 mM sodium phosphate buffer (pH 7), 1 mM
cellopentaose, 0.1 nmol WssF, 0-0.5 nmol WssI and 6 mM pNP-Ac as the acetyl donor. p > 0.05
for all samples, thereby indicating no statistical difference between trials.

5.4. Qualitative Analysis of O-Acetyltransferase activity of WssI
5.4.1. Thin Layer Chromatography
Thin layer chromatography was used to assess acetyltransfer by WssI onto cellulose
oligomers as a direct verification method of acetyltransfer, opposed to using differences in
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activity to indirectly monitor transfer (as shown in Section 5.3.5.). The TLC protocol to separate
the acetyltransfer reactions was optimized with regards to solvents and a mobile phase of ethyl
acetate, water and methanol (6:3:6 v/v) and a staining solution of 𝛼 -naphthol (3% w/v 𝛼–
naphthol in 25:3:2 methanol, sulfuric acid and water), was found to be the best for consistent
separation and detection of the reaction products. The acetyltransfer reaction by AiWssF was
used as the positive control for this experiment (See Figure 26: Panel A). The appearance of a
second spot on the TLC plate (relative to the no enzyme control (-)) indicates the addition of a
polar acetyl adduct onto the cellulose polymer (Figure 26: Panel A by AiWssF). The appearance
of a second spot in the PfWssI reactions was not noted in any of the cello-acceptor assayed
(Figure 26: Panel B). These results indicate that PfWssI did not participate in detectable amount
of acetyltransfer under the conditions tested, despite the fact hydrolysis of the pNP-Ac donor
occurred as normal.
(A)

(B)

-

+

Cellopentaose

(AiWssF)
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+
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(PfWssI)

Cellobiose Cellotriose Cellotetraose Cellopentaose

Figure 26: TLC Plate with Potential Acetyltransfer Enzymatic Reactions of PfWssI with
Cellulose Oligomers.
Assays were performed in 50 mM sodium phosphate buffer (pH 7), 1 mM cello-acceptor, 0.5
µM AiWssF, 3 µM PfWssI and 6 mM pNP-Ac as the acetyl donor. Panel A) Positive control of
AiWssF showing separated acetylated cellopentaose. The (-) denotes cellopentaose negative
control, and (+) denotes the sample of modified cellopentaose by AiWssF. The arrow in this
panel outlines the addition of an acetyl adduct. Panel B) Analysis of PfWssI with various
cellulose oligomers. The (-) denotes the cellulose oligomers, cellobiose, cellotriose, cellotetraose
and cellopentaose as negative controls without protein. Lastly, (+) denotes the corresponding
unmodified cellulose oligomers by PfWssI. These reactions were purified utilizing SPE
carbograph columns, and the samples were separated with a mobile phase of ethyl acetate, water
and methanol (6: 3: 6 v/v) and stained with 𝛼 -naphthol staining solution (3% w/v 𝛼–naphthol in
25: 3: 2 methanol, sulfuric acid and water).
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Acetyltransferase activity of WssI with chitin oligomers was also assayed to explore the
substrate preference of this enzyme. Unlike TLC analysis with varying cellulose oligomers, it
was apparent that the length of chitin affected the mobility of the polymer on the TLC plate in
such a way that visual differences in retention, with the smaller polymer (chitobiose) having the
weakest interaction with the TLC plate and the largest (chitohexaose) having the strongest
interaction. However, similar to the cello-acceptor results, no acetyltransfer to chito-acceptors by
PfWssI was observed with the TLC analysis (Figure 27). It should be noted that the control
reaction of AiWssF with chitopentaose also did not result in acetyltransfer in contrast to that
observed with cellopentaose (Figure 26: Panel A compared to Figure 27). This result suggests
that AiWssF has specificity for acetyltransfer towards cellulose oligomers and that by
association, our work to further assess PfWssI activity should focus on this polymer, as well.
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Chitobiose Chitotriose Chitotetraose Chitopentaose Chitohexaose

Figure 27: TLC Plate for Analysis Potential Acetyltransfer Enzymatic Reactions of PfWssI with
Chitin Oligomers.
Assays were performed in 50 mM sodium phosphate buffer (pH 7), 1 mM chito-acceptor, 0.5
µM AiWssF, 3 µM PfWssI and 6 mM pNP-Ac as the acetyl donor. The (-) denotes the chitin
oligomers, chitobiose, chitotriose, chitotetraose, chitopentaose and chitohexaose as negative
controls without protein. (I) denotes the corresponding sample containing the hypothesized
acetyltransferase reaction with protein. Lastly, the potential acetyltransfer reaction by
acetyltransferase AiWssF (positive control for cellulose oligomer assays) with chitopentaose is
represented by (F +pent). These reactions were purified utilizing SPE carbograph columns, and
the samples were separated with a mobile phase of 2-propanol and 25% ammonia solution (7: 3
v/v) and sprayed with a staining solution containing diphenylamine, aniline and phosphoric acid
in acetone.
With proof of acetyltransfer onto cello-oligomers by AiWssF, a set of experiments were
conducted to analyze the effects and activity of PfWssI in the presence of AiWssF (combined
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“one pot” reactions) or with the reaction products of AiWssF reactions (tandem reactions).
Synergistic effects between two enzymes, including an increase in AiWssF activity and/or the
product of AiWssF serving as a substrate for PfWssI, were anticipated to be observed as new
acetylation species (i.e., new spots on the TLC plate) or increases in spot intensity. In contrast, if
PfWssI was acting as a deacetylase, then a resultant decrease in acetyl-products of the WssF
reaction should be observed. The results of the combined AiWssF and PfWssI experiments did
not lead to a definitive intensity difference or appearance of new acetyl-products between the
individual controls (Figure 28: Panel A, WssF lanes) and combined (Figure 28: Panel A, WssF
and WssI lanes) timepoints for each reaction. However, there was a decrease in overall intensity
for all reactions over the course of the experiment (Figure 28: Panel A, 0.5 hr compared to 24
hrs) that could be due to either the unlikely degradation of the polymer, unequal loading or the
potential deacetylase function of WssI. Regardless, the ratio of unmodified polymer to acetylated
polymer remained consistent in each case; thereby suggesting that AiWssF was the dominant
enzyme leading to the most abundant products. The tandem reactions were specifically designed
to provide more insight into the activity of PfWssI. Briefly, the reaction products of an AiWssF
reaction were purified and then used as the substrate for the subsequent AiWssI reaction.
Following extended incubation, subtle differences over the course of the reaction with PfWssI
were noted. For example, the intensity of the acetylated polymer appears to increase slightly
relative to the unacetylated polymer over time (Figure 28: Panel B, 1 hr compared to 24 hrs).
However, given the qualitative nature of these trials, we elected to examine reaction products by
MS and NMR. However, the abundance of product needed for NMR was prohibitive with
respect to this specific thesis.
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Figure 28: TLC Plate of the Cellopentaose Product PfWssI and AiWssF Combined and Tandem
Reactions.
Assays were performed in 50 mM sodium phosphate buffer (pH 7), 1 mM cello-acceptor, 1: 2.5
mol ratios of WssF and WssI and 6 mM pNP-Ac as the acetyl donor. Panel A) Combined
reactions of WssI and WssF over a time course of 0.5 hr, 1 hr, 3 hrs, 6 hrs and 24 hrs. The (-)
denotes cellopentaose negative control, positive controls with acetyltransfer reaction by AiWssF
denoted as (F) for every time point, and (FI) represent the cellopentaose product modified by
WssI and WssF. B) Analysis of tandem reaction products. Purified WssF acetylatedcellopentaose was used as the substrate for the subsequent WssI reaction (1.12nmol final
concentration) and products of the second reaction were analyzed by TLC after 1 hr, 3 hrs, 6 hrs
and 24 hrs. The cellopentaose negative control is denoted as (-), positive controls of
acetyltransfer reaction by AiWssF is denoted as (+), and (I) represents the reaction by WssI.
These reactions were purified utilizing SPE carbograph columns, and the samples were separated
with a mobile phase of ethyl acetate, water and methanol (6: 3: 6 v/v) and stained with 𝛼 naphthol staining solution solution (3% w/v 𝛼–naphthol in 25: 3: 2 methanol, sulfuric acid and
water).
5.4.2. Mass Spectrometry
The previous samples analyzed by TLC, were sent to the Advanced Analysis centre at the
University of Guelph. The more sensitive analysis method of mass spectrometry was used to
detect acetyltransfer by WssI onto cellopentaose or cellohexaose, which could not be definitively
confirmed by the activity assays and/or TLC analyses. To ensure the reaction had the potential
for acetyl-product, the extended 18-24 hr reactions of PfWssI with cellopentaose (Figure 29) or
cellohexaose (Figure 30) with pNP-Ac as the acetyl donor were analyzed (following purification
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of the product with carbograph columns). MS analysis of the control reactions (Figure 29: Panel
A and 30: Panel A) identified sodium and potassium adducts with the cellopentaose and
cellohexaose substrates. The WssI treated samples possessed the same substrate adducts, but
products consistent with the addition of a single 42 m/z (acetyl group) to both adducts of the
cellopentaose (Figure 29: Panel B) and to the sodium adduct of cellohexaose were observed
(Figure 30: Panel B). Given that the relative intensities of the peaks are difficult to correlate with
abundance of the product, and these acetyl-products were only observed after extensive
incubation, there are still questions surrounding optimization of the reaction and whether the
acetyl transfer is biologically relevant with the synthetic donor. While the testing of longer cellooligomers by this method was prohibitive due to the cost and availability of longer polymers, an
alternative acetyl-donor was tested.
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Figure 29: Mass Spectrum of the pNP-Ac Donor Trials with Cellopentaose.
Assays were performed in 50 mM sodium phosphate buffer (pH 7) containing 1 mM
cellopentaose, 3 µM WssI and 6 mM pNP-Ac as the acetyl donor. The spectra were obtained
through ESI-MS analysis where MS was conducted in the positive polarity mode. Panel A)
Spectra obtained from the no-enzyme control; Panel B) Spectra obtained from the cellopentaose
and enzyme reaction. M denotes the mass of cellopentaose (828 Da), while H+, Na+, K+ and Ac
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denote the addition of a sodium (23 Da), potassium (39 Da) and/or an acetyl group (42 Da) to the
cellopentaose, respectively.
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Figure 30: Mass Spectrum of the pNP-Ac Donor Trials with Cellohexaose.
Assays were performed in 50 mM sodium phosphate buffer (pH 7) containing 1 mM
cellohexaose, 3 µM WssI and 6 mM pNP-Ac as the acetyl donor. The spectra were obtained
through ESI-MS analysis where MS was conducted in the positive polarity mode. Panel A)
Spectra obtained from the no-enzyme control; Panel B) Spectra obtained from the cellohexaose
and enzyme reaction. M denotes the mass of cellohexaose (990 Da), while H+, Na+, K+ and Ac
denote the addition of a sodium (23 Da), potassium (39 Da) and/or an acetyl (42 Da) to the
cellohexaose, respectively.
5.4.3. Enzymatic Activity with Acetyl-CoA
The synthetic acetyl donors pNP-Ac and 4-MUB-Ac were used due to the facile nature of
measuring the colourimetric and fluorescence release of products as quantifiable esterase activity
of WssI. However, the biological acetyl donor substrate of the acetylated cellulose system
remains unknown. With this in mind, acetyl-CoA was tested as a possible substrate due to its
involvement in the metabolism of carbohydrates and lipids within bacterial cells72. A standard
activity assay with acetyl-CoA as substrate was setup and the reaction was allowed to proceed
for an extended period of time (24hr) to permit the generation of products. The appropriate
control (cellopentaose with acetyl CoA and no enzyme; Figure 31: Panel A) and reactions with
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AiWssI (Figure 31: Panel B) and PfWssI (Figure 31: Pane; C) were all separated and assessed
using LC-MS analysis. The control reaction contained the appropriate masses of a cellulose
oligomer with hydrogen and sodium adducts (Figure 31: Panel A), but not acetylated polymer. In
contrast, AiWssI and PfWssI containing reactions possessed the cellopentaose adducts with an
additional mass of 42 m/z, which is consistent with the addition of a single acetyl group onto the
polymer (Figure 31: Panels B and C). Overall, we can conclude that both constructs of WssI
perform transferase activity to transfer acetyl onto the cellulose oligomer over extended periods
with acetyl-CoA as an acetyl donor.
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Figure 31: Mass Spectrum of the Acetyl-CoA Donor Trials.
Assays were performed in 50 mM sodium phosphate buffer (pH 7) containing 1 mM
cellopentaose, 3 µM PfWssI and 4 mM acetyl-CoA as the acetyl donor. The spectra were
obtained through LC-MS analysis where MS was conducted in the positive polarity mode. Panel
A) Spectra obtained from the no-enzyme control; Panel B) Spectra obtained from the AiWssI
reaction; and Panel C) Spectra obtained from the PfWssI reaction. M denotes the mass of
cellopentaose (828 Da), while H+ and Na+ and Ac denote the addition of a hydrogen (1 Da),
sodium (23 Da) and/or an acetyl group (42 Da) to the cellopentaose, respectively.
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5.5. High-throughput Screening of Inhibitors
5.5.1. Storage Conditions
The HTS parameter, Zʹ was used as a quality control unit over time to ensure the activity
of WssI could withstand extensive screening. The Zʹ value depicts the overall compatibility of a
specific enzyme’s activity for HTS assays. A Zʹ value between 0.5-1 indicates that the sample
mean (i.e., positive enzyme reaction) is at least three standard deviations away from the control
mean (i.e., negative reaction-lacking enzyme) and that inhibition between this window can be
confidently reported. Zʹ values from three storage temperatures had slight fluctuations overall,
but it was concluded that -80 ℃ was the most ideal temperature, due to stable Zʹ values across
the 16 days tested (Figure 32). This finding was also an indication that the addition of 10% (v/v)
of glycerol acted as a suitable cryoprotectant to stabilize the precipitation of AiWssI over time
without hindering the activity significantly. As shown in Figure 32, the third day of the analysis
indicated a low Zʹ value for both the -20 ℃ and -80 ℃ samples, but by the sixteenth day, both
samples were back within the appropriate range, thereby eliminating 4 ℃ as an optimal storage
temperature. These results were important as they laid the foundation for storage (for transport
and screening time) of the high quantities of enzyme prior to analysis at SPARC BioCentre,
which was finalized to be at -20 ℃ in 10% (v/v) of glycerol.
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Figure 32: Time-point Analysis of Zʹ Values.
Assays were performed in 50 mM sodium phosphate buffer (pH 7) containing 3 µM AiWssI and
0.5 mM 4-MUB-Ac as the acetyl donor. Zʹ values of three storage conditions on time points day
1, 3, 6 and 16 were assessed. The decline in Zʹ for the 4 ℃ sample was an indication that -20 ℃
and -80 ℃ were the most suitable storage conditions, with -80 ℃ having the most consistent
results.
5.5.2. High ThroughPut Screening (HTS)
The high throughput screening process was initiated with assay optimization prior to
performing the primary and secondary screens to ensure that AiWssI was compatible for
screening. Initial assay trials were performed using samples of WssI at the SPARC BioCentre.
The optimized assay conditions for HTS were 50 mM sodium phosphate buffer, pH 6.5, 3 µM of
WssI and 0.5 mM of 4-MUB-Ac, with the addition of 20 µM of compounds. Through every
separate purification, AiWssI had Zʹ values ranging from 0.6-0.8 each time the protein was
assayed at either the SPARC BioCentre and in-house.
The primary screen of WssI, using the above noted assay conditions, involved testing
against 17,911 compounds and this screen yielded 11 hits with a Z score ≤ -3 (three standard
deviations from the no enzyme control). These compounds in addition to hits from screens of
WssF, PatB and OatA (other cellulose and peptidoglycan acetyltransferases), totalled 146
compounds (Figure 33) that were selected for a secondary screen. These compounds were
assayed in triplicate to verify the primary screen results (performed singly) and the results lead to
confirmation of approximately 40 hits with at least two of the three replicates with Z scores less
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than -3. These compounds are represented in Figure 33 as luminescence (lum) Z scores against
inhibitory effect (% inhibition) shown with yellow to green circles, where the gradient towards
green denotes increasing inhibition. These 40 compounds were analyzed for Pan Assay
Interference Compounds (PAINS) using Tables 11 and 12 from Baell and Holloway73 for
substructures that may cause assay interference and false positive hits. Through consult with a
colleague, Dr. Mark Nitz (University of Toronto), approximately 26 compounds were identified
with minimal PAINS and had substructures that were amenable to downstream medicinal
chemistry manipulations. Further trials with WssI and these 26 compounds were analyzed using
dose response curves for each of compound against AiWssI, reported as an inhibitory
concentration at 50% of the maximum value (IC50 values). The 26 lead compounds, in addition
to 12 other compounds from the primary and secondary screening (included based on their high
inhibition in these early screens) were assessed at the SPARC BioCentre for potential false
positive results caused by fluorescence quenching (i.e., false inhibition). After careful
consideration and consultation, a finalized list of 12 compounds were chosen and purchased for
further analysis (Table 2 and 10). These compounds exhibited suitable Z scores, adequate
percent inhibition of WssI in primary or secondary screens and/or had dose responses that lead to
relative saturation, 100% inhibition of AiWssI, as well as having chemical features that were
amenable to downstream chemical manipulation (through consultation with Dr. Nitz).
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Figure 33: CDD Vision Plot of Secondary Screen luminescence % Inhibition Against
Luminescence Z score.
Colour scale represents percent inhibition of compound with WssI and optimal Z score values.
Figure rendered from Vision feature of the Collaborative Drug Discovery (CDD) Vault.
5.5.3. Inhibitor Assays with Lead Hits from HTS
The 12 compounds selected from HTS were purchased and tested against AiWssI to
verify enzyme inhibition in-house. The compounds were renamed alphabetically and tested at
concentrations approximately double the reported IC50 value by Adam Deruchie-Tan (Table 10).
If the compound had not been tested in HTS dose response assay (i.e., no reported IC50 value),
the compound was tested at 20 µM and 100 µM to develop an initial range of potential
inhibition. Due to the challenges such as compound precipitation and fluctuating fluorescence
readings, the assays with compounds E, F, I, J and K revealed variable calculated percent
inhibition values, which made the assay difficult to reproduce even after the trials using pNP-Ac
as the acetyl donor instead of 4-MUB-Ac. These compounds were deemed unsuitable for further
analysis. The compounds with the highest percent inhibition were compounds D and H, which
resulted in 69% inhibition of AiWssI activity. Dose response curves were repeated in-house for
compounds A, D and H (Figures 34-36: Panel A) and compared against the dose response curves
provided from SPARC (Figures 34-36: Panel B). Compound A was the only one of the three
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compounds that reached complete saturation of protein inhibition (100%) at the highest
concentrations of 215 µM (Weadge lab curves) and 159.1 µM (HTS curves) (Figure 34: Panels
A and B). The IC50 values for compounds D and H were higher in the HTS trials (85.3 µM and
60.2 µM, respectively) compared to the Weadge Lab tabulated values of (41.36 µM and 22.57
µM, respectively) (See Table 10). However, these discrepancies should be interpreted with
caution since the curves did not reach 100% inhibition, but the IC50 values are certainly in the
low micromolar range for these compounds.
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Table 10: Finalized List of Compounds from HTS and Subsequent Screening.
Compound
Name

CDD Vault
ID number

Tested
Concentration

% Inhibition**

HSC0002596

HTS
IC50
Values*
10.1 µM

Compound
A†
Compound B

Tabulated
IC50
Value**
28.41 µM

20 µM

16.5 +/- 0.95%

HSC0113332

51.9 µM

100µM

8.8 +/- 3.9%

-

Compound C

HSC0104541

55.3 µM

100µM

16 +/- 6%

-

Compound D

HSC0109757

85.3 µM

175µM

69.7 +/- 4.3%

Compound E

HSC0054645

-

Compound F

HSC0055255

-

Compound G

HSC0098657

74.7 µM

20µM and
100µM
20µM and
100µM
100µM

(8.5 +/- 7.3%) and
(-20.7+/- 5.5%)
(-37.7 +/- 5.5%) and
(1.5 +/- 6.9%)
39.4 +/- 4.7%

Compound H

HSC0007989

60.2 µM

100µM

68.9 +/- 6.0%

Compound I

HSC0006734

-

41.36µM
22.57µM

20µM and
(-34.9 +/- 23.8%) and 100µM
(0.16 +/- 8.66%)
Compound J HSC0055185 20µM and
(-47.3 +/- 8.8%) and
100µM
(-6.3 +/- 17.3%)
Compound K HSC0065256 20µM and
(-17.5 +/- 8.8%) and
100µM
(13.4 +/- 6.3%)
Compound L HSC0063093 25µM and
(-8.0+/- 16.9%) and
75µM
(-33.7+/- 24.8%)
†Compound A is also referred to as the commercial compound Tyrphostin AG112 74,75.
*Assays performed during HTS screening.
** Assays performed in-house.
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Figure 34: Dose Response Curves of AiWssI and Compound A with 4-MUB-Ac as the
Substrate.
Panel A) Dose response curve of percent inhibition of AiWssI against 0-215 µM of compound A
with a reported IC50 values of 28.41 µM (Weadge Lab). Panel B) Dose response curve of percent
inhibition of WssI against 0-159.1 µM of compound A with a reported IC50 values of 10.1 µM
by the SPARC BioCentre.
(B)
% Inhibition

(A)

Figure 35: Dose Response Curves of AiWssI and Compound D with 4-MUB-Ac as the
Substrate.
Panel A) Dose response curve of percent inhibition of AiWssI against 0-215 µM of compound D
with a reported IC50 values of 41.36 µM (Weadge Lab). Panel B) Dose response curve of percent
inhibition of WssI against 0-159.1 µM of compound D with a reported IC50 values of 85.3 µM
by the SPARC BioCentre.
(B)
% Inhibition

(A)

Figure 36: Dose Response Curves of AiWssI and Compound H with 4-MUB-Ac as the
Substrate.
Panel A) Dose response curve of percent inhibition of AiWssI against 0-215 µM of compound H
with a reported IC50 values of 22.57 µM (Weadge Lab). Panel B) Dose response curve of percent
inhibition of WssI against 0-159.1 µM of compound H with a reported IC50 values of 60.2 µM
by the SPARC BioCentre.
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6. Discussion
6.1. Protein Expression and Purification (Objective 1)
The expression and purification of WssI was a challenging endeavor throughout this
thesis. Expression conditions were previously assessed by Ms. Janice Prescod and Ms. Emily
Wilson (former Weadge lab members) and these researchers noted that WssI expressed at lower
temperatures (approximately 17 ℃) for 4 hrs with the addition of 3% (v/v) ethanol to prevent
degradation by induction of chaperones in E. coli76. The conditions were further optimized by
growing the cells in prewarmed super broth media and expressing WssI without ethanol at 17℃
for 16-18 hrs to maximize the overall production of WssI. The E. coli Rosetta Codon plus cells
were also found to be better expression hosts than E. coli BL21, likely due to the presence of rare
tRNA genes in these cells that overcome codon bias that may have been inherent between E. coli
and the Achromobacter and Pseudomonas species77. The combination of the altered conditions
of using a different expression host and introducing protease inhibitors during cell lysis for
purification, improved the overall protein yield after IMAC purification by approximately 0.5
mg/L of culture.
Other challenges encountered with respect to protein expression and purification was the
reoccurrence of WssI eluting from the IMAC column in the presence of a ~25 kDa E. coli
chaperon, SlyD (confirmed through gel extraction and MS sequencing). The removal of salt from
the protein buffer prior to anion exchange, decreased the overall yield of protein, including some
quantity of WssI. However, despite the precipitation, the secondary purification method eluted
the SlyD contaminant of both AiWssI and PfWssI, leaving an overall improvement in purified
WssI protein, with quantities of each construct amenable for functional assays.
Overall, total protein yield after IMAC purification from the AiWssI construct was
typically 0.8 mg and 1.5 mg for the PfWssI construct from 1 L of culture after introducing the
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expression conditions. In comparison, the yield of protein after anion exchange purification was
0.125 mg of AiWssI and 0.25 mg of PfWssI from 1 L of culture. This finding explains the loss of
a large quantity of contaminates with an additional loss of the target protein retained on the anion
exchange column. However, the purification methods still yielded a suitable amount for
functional assays. Future directions to continue working on optimizing expression conditions or
switching to N-terminal constructs could improve yields for later structural studies. Overall,
objective 1 was accomplished due to the successful purification of AiWssI and PfWssI despite
low yields, because the quantity and quality of the protein was suitable for all downstream assays
presented in this thesis.

6.2. Characterization the Function of WssI (Objective 2)
6.2.1. WssI Esterase Characterization
The mechanism of action and substrate specificity of WssI was explored through various
in vitro assays. Since the proposed function of WssI is as an acetyltransferase, this constitutes the
progression of the reactions that can be separately assessed by different acceptors; cleavage of
the acetyl donor substrate, followed by transfer onto water (esterase reaction) or the transfer onto
a cellulose acceptor (transferase reaction) (Figure 8 for predicted mechanism). With the use of
the commercially available acetyl donors pNP-Ac and 4-MUB-Ac (Figure 18), the activity of
WssI was optimized for later characterization. Specifically, buffer conditions were tested to
identify the optimal buffer pH. As shown in Figure 19, profiles exhibit the bell-shaped curve,
with the highest percent specific activity at pH 8.5. The bell-shaped pH profile can cause
speculation that a protonation-deprotonation event was occurring, as the curve may be consistent
with two ionizable groups such as the imidazolium ring of histidine (pKa value of 6.04). This
finding is only a prediction based off of similar bell-shaped pH profiles from peptidoglycan
deacetylase and acetyltransferase, Ape1 and PatB44,79. The profiles of Ape and PatB were
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assessed with kinetic parameters at each pH value which confidently reported the protonationdeprotonation event by the catalytic histidine, adding to the function of this residue within the
catalytic mechanism for acetyltransferases (Figure 8)45,70,78. The last important finding of the pH
profile was the pH in which WssI displays the highest activity, 8.5. The biological relevance of
this predicts that the enzyme is likely working below its optimum, since the pH of the periplasm
(where the protein is predicted to reside) is lower (estimated to be between pH 5.5-7.5)79.
However, the lower activity may be inherent in appropriately matching the production rate of
cellulose by bacteria. Due to the physiological location in which WssI resides in the biological
system, a sodium phosphate buffer with a pH of 7 was chosen as the optimal buffer in
maintaining a rate of activity for assay quantification.
Buffer additives were also examined with respect to stabilizing agents and their effects on
WssI activity. Specifically, WssI had 10.65 +/- 5.60% residual activity when DTT was removed
from all purification and storage buffers, leading to the conclusion that the activity of WssI is
sensitive upon the presence of DTT. This dependence was hypothesized to be due to the two
cysteine residues present in each WssI construct (provided by ProtParam) that form a disulfide
bond within the protein structure (Figure 11). Although puzzling due to the oxidative periplasm
environment WssI is predicted to reside, the reduced cysteine residues are important for enzyme
activity while the oxidized form may lead to blockage of the active site from properly binding to
the acetyl-donor. This result is in contrast to other acetyltransferases (i.e., AlgX) that have two
disulfide bonds in a region neighbouring the active site and are functional in the absence of
reducing agents35. Overall, the effects with other reducing agents in future experiments will
support a final analysis of the functional importance of the predicted disulfide bond. Lastly,
glycerol was also used as an additive to stabilize WssI during storage condition testing.
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As outlined above, WssI esterase activity was verified and optimized for the first time at
the biochemical level and these foundational experiments led to the ability to further examine
substrate profiles and kinetics for both versions of the WssI enzyme. Both of these enzymes were
more active with pNP-Ac as the acetyl donor. Interestingly, PfWssI was more active than AiWssI
(catalytic efficiency parameter (kcat /KM) of 3.23 M -1·s-1 and 1.77 M -1·s-1, respectively), which
can be observed in the bar graph of Figure 22. This trend was carried out with the kinetics
presented in Section 5.3.4 with the PfWssI Michalis Menten constant (KM) value of 2.48 +/- 0.91
mM, which was also similar to the KM value of AiWssI (2.31+/- 0.43 mM). However, the turn
over number (kcat) values showed that PfWssI can turn over slightly more substrate in a period of
time than AiWssI with kcat values of 7.99 x10-3 +/- 9.98 x10-4 s-1 and 4.05 x10-3 +/- 2.46 x10-4 s-1,
respectively. These results demonstrate that, while the enzymes share homology and 62%
similarity, there are subtle differences that may be tuned for their respective biosynthetic
systems. For example, the PG acetyltransferases OatA from Streptococcus pneumoniae
(SpOatAc) and Staphylococcus aureus (SaOatAc) have catalytic efficiencies (kcat /KM) of 289 M1

∙ s-1 +/- 43 and 52.3 M-1∙ s-1 +/- 0.001 with pNP-Ac as the acetyl donor, thereby, representing a

similar trend between the different WssI constructs63.
It is important to note that the reported catalytic efficiency values for WssI are much
smaller in magnitude in comparison to the peptidoglycan acetyltransferases OatA (mentioned
above), and PatB (kcat /KM value of 797 M-1∙ s-1 +/-88) with pNP-Ac as the acetyl donor48. This
demonstrates that WssI is not a strong esterase or acetyltransferase protein, suggesting a
modified role involving in the acetylation of cellulose. This proposal is supported by very similar
kinetic parameters reported with WssI and the homologous esterase/transferase AlgJ (kcat /KM
value of 3.39 +/- 0.0688 M-1∙ s-1)34. The presence of two predicted acetyltransferases was
consistent between the Wss (WssF and WssI) and Alg (AlgJ and AlgX) systems, but the need for
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two acetyltransferases was unknown. We hypothesize that the addition of another
acetyltransferase may have occurred due to evolutionary need to keep up with the increasing rate
of synthesis and export of cellulose/alginate polymers within a rapidly growing biofilm. The
WssI and AlgJ proteins were the predicted acetyltransferase proteins, while WssF and AlgX had
unknown functions20,54. Therefore, in some bacterial systems WssI and AlgJ may have
functioned alone until the need for the expression of wssF and algX, which function as
acetyltransferases at a rate consistent with the synthesis and export.
6.2.1.1.

Assessment of WssI activity with Commercially Available Inhibitors

To gain insight into the catalytic mechanism of WssI, common inhibitors of
proteases/lipases/esterases (which fall into the same broad enzyme classification) were tested by
incorporating the agents into activity assays. Protease inhibitor cocktail tablets, that contain a
combination of serine, cysteine, aspartic-acid and aminopeptidase inhibitors (specifically
containing Aprotinin, Bestatin, E-64, Leupeptin, AEBSF and Pepstatin A), were assessed for
their effect on WssI activity because they were initially part of our purification scheme to reduce
protein degradation during purification. In the presence of this inhibitor mixture, the activity of
WssI reduced dramatically to 2.2 +/- 0.3% residual activity. The inhibitor trials with PMSF and
MSF were meant to compliment the protease inhibitor cocktail trials because both PMSF and
MSF are known inhibitors of catalytic serine nucleophiles (in serine proteases and acetylcholine
esterases, etc.)69, which is also predicted to be a conserved feature of WssI. However,
abolishment of activity after extensive exposure to elevated concentrations (i.e., above the listed
manufacturer working concentration of 1 mM for PMSF80) of these inhibitors was not observed.
It should be noted that the lack of inhibition by PMSF was initially hypothesized to be due to the
inability of PMSF to covalently bind the serine active site residue. The additional phenyl group
of PMSF may have been preventing the chemical from sterically accessing the active site, but
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after elevating the PMSF concentration to force the interaction, the high PMSF concentrations
led to PMSF precipitating out of solution. However, the chemical analog, MSF (possesses a
methyl group instead of the bulky phenol group) did not lead to complete inhibition either. While
puzzling, these results are in contrast with previous work done by colleagues testing protein
inhibition of peptidoglycan O-acetyltransferase, PatB, which had 38% inhibition by PMSF;
however, some unconventional serine proteases with variations of the Ser-His-Asp catalytic
residues do not exhibit inhibition by PMSF. Therebefore, this implies that PMSF and in some
cases MSF, are not suitable inhibitors for some serine proteases due to the lack of complete
abolishment of activity, likely due to the inability to access the active sites, or due to residual
activity facilitated by surface residues45,69.
With findings that the common serine protease inhibitors were ineffective at inhibiting
the activity of WssI, we also explored the possibility that the aspartic acid or cysteine catalytic
residues (present in other proteases/esterases, but not all conserved in WssI) may be the catalytic
nucleophile80–82. Specifically, the effects of aspartate protease inhibitor, Pepstatin A, and
cysteine protease inhibitor, E-64, were incorporated into assays at increasing concentrations.
However, similar to the PMSF and MSF results, no detectable inhibition of WssI was observed
with Pepstatin A or E-64 (See Table 5). This result implied that although the combination of
protease inhibitors diminished the activity of WssI, the selected chemical inhibitors were not
effective individually. Lastly, to further characterize the active site of WssI, EDTA was tested to
determine if WssI activity was metal dependent. With this metal chelator, there was a 10%
decrease in the esterase activity of WssI; however, this inhibition was not significant enough to
predict that WssI is a metalloenzyme and instead may be due to the fact that metals bound for
protein stability were lost, since protein degradation was observed during incubation with 5mM
of EDTA. Other acetyltransferase proteins such as PatB, also do not exhibit metalloenzyme
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properties, due to the lack of inhibition of PatB by incubation with EDTA, similarly to WssI48.
This result further outlines that metals are unlikely to be involved in catalysis by
acetyltransferase proteins. Overall, commercially available inhibitors (aside from the protease
tablet cocktail) all proved ineffective at inhibiting WssI. These results add to the importance of
the research centred around HTS and mutagenesis exploration of carbohydrate acetyltransferase
inhibitors in general and more specifically as a WssI targeted inhibitor (both described below).
6.2.1.2.

Active Site Mutant Analysis of WssI

To complement inhibitor trials, the generation of site directed mutants was designed to
directly explore the mechanism of action of the conserved residues of WssI that form a Ser-HisAsp catalytic triad in other acetyltransferases34,45,83,84. The generation of site directed mutants
was challenging as two separate sets of primers were designed and attempted. The second set of
primers were optimized to decrease the potential for primer dimers, and hairpins associated with
the sequences, and were successful in mutating three of the six targeted mutants under various
PCR conditions such as touch down PCR. The subsequent expression and purification of
AiWssIH211A, AiWssIS309A and PfWssIS304A was also challenging with total yields of less than 0.1
mg/L of culture each. Following IMAC purification, the constructs of AiWssI containing the
gene mutations were isolated with greater purity and PfWssIS304A nearly complete purity by
anion exchange. Thus, despite the challenges of expression, the purification process was
successful and yielded adequate quantifies of protein for subsequent assays.
Even though only half of the proposed SDM mutants were generated and purified, two of
the constructs contained critical mutations of the proposed nucleophilic serines of the
Achromobacter and Pseudomonas WssI enzymes. In other trials with esterases/transferases AlgJ
and PatB, similar mutations have led to the greatest resultant decrease in activity34,45. For
analysis, the standard assays were also performed using both commercial acetyl-donors to
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compare differences in inhibition. The results of these assays with pNP-Ac revealed that all of
the generated gene mutants had between 20-50% less esterase activity in comparison to the
respective wild type proteins (Table 9 and Figures 37 and 38: Panel A). In the presence of 4MUB-Ac as the acetyl donor, AiWssIS309A had the same level of loss of esterase activity as pNPAc, but the loss of esterase activity for AiWssIH211A and PfWssIS304A enzyme variants was greater
with the 4-MUB-Ac substrate (reductions compared to wild type of approximately 50% and
40%, respectively). The results also outline that the gene mutation of histidine to an alanine
residue had a greater inhibitory effect in comparison to the wild-type and of the gene mutation of
serine to alanine. Therefore, these finding outline that the activity of WssI may be more
dependent upon a functional histidine active site residue in contrast to the proposed nucleophilic
serine.
In parallel studies (unpublished work of Cody Reese in the Weadge Lab), the
independent mutation genes encoding the three Ser-His-Asp catalytic residues for the
acetyltransferase, WssF, did not lead to complete inhibition of esterase activity either. Analysis
of the AiWssFS17A, AiWssFD188A and AiWssFH191A with 4-MUB-Ac donor led to 25%, 13% and
25% remaining activity, respectively85. In previous findings with site directed gene mutations of
the Ser-His-Asp encoded residues of the alginate acetyltransferase homolog, AlgJ, all of the gene
mutants had reduced activity by approximately 80%34. Since the mutants of WssI only lost a
maximum of 50% esterase activity, it is possible that 1) the coordination of the acetyl-donor in
the active site could still lead to a low enough activation energy that results in hydrolysis even in
the absence of the catalytic nucleophile, 2) the remaining activity could be due to off target
hydrolysis, or 3) the mutations selected are not the catalytic residues despite high sequence
conservation. To address the issues of whether the residues are true catalytic residues,
combinatorial mutations could be made in future experiments. With respect to the timeframe of
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this thesis, the role of the WssI gene mutants were further explored by analyzing specific
transferase activity (described below).
6.2.2. Cellulose Binding Assays with WssI
To better understand the potential of WssI to specifically bind increasing lengths of
cellulose acceptors, an avicel binding assay was performed to more closely mimic the length of a
polymer this enzyme would contact in vivo. This assay was performed with the hypothesis that,
if WssI had affinity for avicel, WssI would remain bound to avicel throughout an extensive
washing process, that should remove non-specifically bound proteins. With increasing
concentrations of WssI, there was also a corresponding increase in WssI bound to the insoluble
avicel pellet, thereby indicating specific binding of this enzyme to this substrate. The converse
experiments also held true, where increasing avicel concentrations bound increasing amounts of
WssI (which was held constant in the assay), further confirming WssI’s specificity. However, in
both cases the ratio of protein bound was far smaller than the amount of free enzyme in the
supernatant and may be suggestive of overall weak binding of a non-optimal substrate (i.e., fibral
organization of crystalline plant vs. amorphous microbial cellulose) and/or be an artefact of the
artificial assay conditions (i.e., poor mimic of the biological context of the cellulose biosynthetic
system). The evidence of weak binding of WssI to avicel is comparable to a predicted homolog
of the alginate system, AlgJ. Using similar binding assays, AlgJ and AlgX were characterized to
explain the presence of two proposed alginate acetyltransferase proteins. As previously
mentioned, in the acetylated cellulose system, WssI and WssF are not only homologues of the
alginate proteins, but also have the similar predicted structures and function. The structure of
AlgX44-344 (close homolog of WssF), contained a deep electropositive groove and a C-terminal
carbohydrate-binding module that is compatible with binding the net-negative alginate polymer
and this was further verified by ESI-MS34. However, by the same method, AlgJ could only be
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observed at lower charged states to bind alginate due to a fraction of unfolded protein in solution
and bound very weakly (proven with Ka value less than 500 M-1)34. Since WssI’s closest known
homolog is AlgJ with similar kinetic parameters as mentioned above, it may be that WssI’s weak
binding to cellulose (although an uncharged polymer) may be due to the absence of an extending
binding surface or accessory protein. In a similar capacity, the shared weak esterase abilities of
both proteins in addition to the weak binding of the polymer may support the predicted role of
WssI as the transition between the MBOAT protein which brings the acetyl group into the
periplasm, and the true acetyltransferase34.
6.2.3. Indirect Measure of Transferase Activity with Activity Assays
With knowledge that WssI binds weakly to a cellulose mimic, the transfer of an acetyl
group onto the polymer was explored utilizing the standard activity assay in the presence of a
commercial cello-acceptor, cellopentaose. While standard assay allowed characterization of the
esterase function of WssI, the use of this assay to uncover evidence of transferase activity was
not as straightforward. The transferase activity with pNP-Ac of AiWssIS309A remained unchanged
in comparison to AiWssI WT esterase activity, while the transferase activity of AiWssIH211A
decreased with 75% remaining activity, and PfWssIS304A had 80% remaining activity compared
to the WT, similarly to the mutant’s esterase activity (Table 9). Of note in these experiments is
that the activity of AiWssI WT increased to 113% residual activity in the presence of
cellopentaose, while PfWssI WT activity remained the same with cellopentaose present and
pNP-Ac as the acetyl-donor (See Table 7). This result is consistent with previously established
kinetic parameters (described above), where AiWssI had a slight increase in specific activity with
cello-oligomers present, unlike PfWssI.
The potential specificity of AiWssI for particular acceptor lengths, which may also be
influencing the lack of PfWssI acetyltransfer, was further explored with the activity assays. In
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the presence of cellotriose and cellotetraose acceptors, a statistically significant decrease in
activity was noted for PfWssI and the other tested acceptors yielded no change above the
background esterase activity (see Table 7 and Figure 22: Panel A). Thus, the results for PfWssI
are consistent in that none of the cello-acceptor lengths tested in any of the assays led to
noticeable increases in activity. In contrast, AiWssI had statistically significant increases with
increasing length of polymer, with the exception of cellotriose (Table 8 and Figure 22: Panel A).
Although these assays do not confirm acetyltransfer onto the polymer, these results may provide
further indirect evidence that AiWssI activity was influenced by the cello-acceptors and that it
may be able to transfer an acetyl group onto the cellulose polymer. The differences between the
two enzymes’ potential for acetyltransfer onto cello-acceptors are particularly noteworthy, given
that the catalytic efficiency (kcat/KM) of PfWssI was higher than that of AiWssI (as noted above)
for esterase activity. Future kinetic experiments involving both substrates may help to better
understand these differences.
The specificity of WssI towards cellulose oligomers was compared to assays with the
related polymer, chitin, since oligomers of chitin were previously demonstrated to serve as
acceptors of acetyltransfer for the WssI homolog, the PatB peptidoglycan acetyltransferase46.
Chitin is a 𝛽-linked polymer of N-acetylglucosamine (GlcNAc), and was used in PatB studies as
a related polymer to peptidoglycan (alternating GlcNAc and N-acetylmuramic acid (MurNAc)
residues)44. In the presence of chitobiose and chitotetraose acceptors, a statistically significant
decrease in activity was shown with PfWssI, while other tested chitin-acceptors yielded no
change (Figure 22: Panel B). In contrast to the cello-acceptor study, AiWssI yielded no change in
activity above the background for all acceptor lengths (Figure 22: Panel B). Therefore, the lack
of change in activity in the presence of chitin-acceptors, outlines that PfWssI and certainly
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AiWssI may have a slight preference towards the cellulose acceptor if at all, in comparison to the
peptidoglycan related polymer (Further analyzed in TLC findings explained in Section 6.2.4.).
The overall esterase function by WssI has been proven in this thesis as novel research.
However, the transferase reaction onto cellulose was difficult to prove and thereby may suggest
that the function of WssI may also be influenced by other Wss proteins, since these proteins have
been proposed to all function to acetylate cellulose in vivo (WssFGHI)22. To specifically explore
this possibility, combinatorial assays with WssF, a partner acetyltransferase in the system, were
attempted. Synergistic reactions were hypothesized to exhibit enhanced rates of reaction with the
proteins together, as opposed to either alone. However, rate of pNP release in the combination of
WssF and WssI did not lead to significant changes presented in Figure 25. The increasing
additions of WssI did not appear to increase the rate of the 0.1 nmol WssF acetyltransfer
reaction, even with attempts with 0.05 nmol of WssF and up to 1 nmol of WssI to observe the
effects of WssI on a broad scale.
The results were confounding as two proteins, which actively cleave pNP-Ac did not
display high rates of pNP release. The unchanged rate of pNP release by the proteins could be
explained by the absence of WssG, which would enhance the synergistic acetyltransferase effects
of WssF and WssI. As shown in Figure 6, WssI is a transmembrane protein, and WssF and WssG
reside in the periplasm. The WssI construct in vitro only contains the periplasmic domain,
however in vivo predictions may explain that WssI obtains the acetyl donor by WssH, cleaves the
ester bond in the periplasm, and WssG aids in the relay of the acetyl group to WssF, which later
transfers the adduct to the polymer. Future experiments to support the results of this thesis by
combining WssG into the assays could help explain if WssG was the accessory protein required
for detectable acetyltransfer in vitro.
6.2.4. Thin Layer Chromatography
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Since the activity analysis suggested that WssI (AiWssI in particular) may acetylate celloacceptor substrates, specific separation and analysis of the cello-acceptor product was performed.
TLC separation and detection was successfully employed for this purpose. While acetyltransfer
onto cello-acceptors was noted for the WssF positive control (exemplified in Figure 26: Panel A
as a new spot on the TLC plate), there was no detectable difference between the negative control
and PfWssI treated samples. The absence of secondary spots for the WssI TLC reactions tested
was in contrast to earlier results that suggested acetyltransfer may have taken place (Figure 26:
Panel B).
To parallel the cellulose specific activity assay, chito-acceptors were also tested and
analyzed by TLC (See Figure 27). However, the alternate chito-acceptors were not acetylated by
WssI either. An important finding in the chitin oligomer TLC analysis was the absence of
acetylated product in the control WssF sample; thereby indicating that WssF has substrate
specificity for cellulose and not chitin-based polymers. By association in the same biosynthetic
complex, it is unlikely that WssI can acetylate chitin-based polymers either. Thus, the question
remained of whether WssI could only bind cellulose with weak affinity (as displayed by the
avicel binding assays) or it could also transfer an acetyl group onto cello-oligomers (as suggested
by the activity assay results).
With the knowledge that WssF acetylates the cellulose polymers, a series of
combinatorial reactions were designed to see if WssI transferase activity could be enhanced (and
more easily detected) in the presence of WssF. The combination of WssF and WssI (Figure 28:
Panel A) did not enhance the acetyltransfer as visualized by TLC and instead showed a potential
decrease in acetyl-product by the overall decrease in spot intensities, raising the possible function
of WssI as a deacetylase protein. Although there is no evidence stating that WssI is homologous
to the carbohydrate esterase family 4 (CE4), peptidoglycan deacetylase proteins Streptococcus
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pneumoniae esterase, PgaA, which deacetylate polyglucosamine (PGA) or, the peptidoglycan
esterase Ape, which cleaves the acetyl group off of peptidoglycan for continual metabolism by
lysozymes; due to the lack of structural knowledge of the Wss proteins, the cleavage of the
acetyl group from a polymer by WssI could not be ruled out8,44,83,86,87. However, the findings
from Figure 28: Panel B counter this prediction due to the increase in intensity of the acetylated
polymer relative to the control, thereby outlining that the intensity of the bands should not be
used as a measurable tool for acetylation. In addition, although acetyltransfer was not detected by
TLC, this finding adds to the verification that WssI has weak affinity for cellulose alike AlgJ for
alginate, because the weak binding and potential modification was only detectable by the more
sensitive mass spectrometry technique (see below). It is assumed that strong binding would
correlate to strong acetyltransfer, which could be observed by TLC similarly to the WssF
positive control.
6.2.5. Mass Spectrometry Assessment of WssI Acetyltransfer
With evidence suggesting potential acetylation (Section 5.3.5.) and weak affinity for
cellulose (Section 5.3.6.), the more sensitive MS verification method was attempted. The
potential acetyltransfer onto cellopentaose and cellohexaose by both versions of WssI were
analyzed by MS. Unfortunately, the AiWssI treated samples were contaminated and beyond the
scope of this thesis to repeat at this time. However, PfWssI treated samples (and the appropriate
controls in Figures 29 and 30: Panel A) revealed acetyltransfer onto both the tested celloacceptors after extended incubation (Figures 29 and 30: Panel B). The sensitivity of the MS
detection is underscored by the fact that the trends in specific activity analysis using activity
assays were not an appropriate method to confidently report transferase activity onto a cellulose
polymer, and homolog AlgJ polymer binding was also only detectable by MS similar to this
thesis. The result is even more compelling as a future experiment involving AiWssI
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acetyltransfer, since AiWssI displayed increases in specific activity consistent with cellulose
oligomer size. Thus, the acetyltransfer products of the AiWssI reactions may be even more
evident in shorter time frames.
The choice of pNP-Ac and 4-MUB-Ac throughout this research was strategic due to the
colourimetric and fluorescent chemical properties of the formed products, thereby providing
quantifiable data for enzyme characterization. With the understanding that the synthetic
substrates were not biologically relevant to the acetylated cellulose system, reactions with acetylCoA were assessed using liquid chromatography mass spectrometry (LC-MS) for high accuracy
of potential acetyltransfer. Results in Figures 31: Panels B and C indicate a successful
acetyltransfer reaction by AiWssI and PfWssI in comparison to the negative control (Panel A),
by the addition of an acetyl group adduct (42 m/z) in both WssI reactions. However, the small
peaks indicating acetylated cellulose by WssI (Figures 29-31), blend into the background noise
of the spectrum unlike spectra indicating strong acetyltransfer by peptidoglycan Gram-negative
acetyltransferase PatB with pNP-Ac45,63. Although acetyl-CoA was predicted to be the biological
substrate in the OatA pathway, the acetyltransfer by OatA with acetyl-CoA as the donor was not
detected by MS implying that the acetyl donor for all biosynthetic systems vary47,63. Overall, the
MS findings suggest that WssI aids in the transfer of the acetyl group after the cleavage of the
donor over a large time period. This is supported by the negative controls (Panels A in Figures
29 -31), suggesting that non-catalytic transfer did not occur over 24 hrs and enforces the fact that
the biological substrate may increase the reaction and/or the presence of the other WssFGH
proteins are required for strong acetyltransfer.

6.3. High Throughput Screening Inhibitor Analysis (Objective 3)
Although WssI may not be the prominent acetyltransferase protein, its function is critical
in the overall acetyltransfer of an acetyl group to cellulose polymers prior to export for biofilm
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formation. The total knock out of WssI activity by chemical inhibitors (outlined in Table 5,
including PMSF, MSF and EDTA) prompted the use of high throughput screening as a method
to identify compounds that can aid in the probing of the mechanistic attributes of WssI, and as
possible inhibitors of acetyltransferases that can affect biofilm formation.
Twelve compounds were selected with confidence from suitable Zʹ and inhibition values
from the HTS primary screen, hit confirmation, dose response and fluorescence quenching
assessments (Table 10). Specifically, compounds A, D and H were successfully assessed for IC50
values by Adam Deruchie-Tan in comparison to the IC50 curves from CDD Vault of the SPARC
BioCentre (Figure 34-36). The expected sigmoidal curve and complete inhibition was prominent
in the HTS IC50 curve of compound A (Figure 34: Panel B), however the IC50 produced in-house
reached approximately 90% inhibition, unlike the HTS curve (Figure 34: Panel A). Although
complete inhibition was not achieved, the consistent low IC50 values (28.4 µM and 10.1 µM,
from in-house and HTS, respectively) confirm that compound A is a suitable inhibitor for WssI
and future studies will apply this compound to microbial biofilms for in vivo assessment.
Compounds D and H were chosen for IC50 analysis despite high micromolar
concentrations required for an inhibition response. Both curves in Figure 35 and 36 did not
outline a clear sigmoidal curve indicating that inhibition of WssI was leveled off at high
concentrations of compound. This implied that although inhibition was reached at high
concentrations of Compound D and H, the protein was not saturated by the compounds.
Although the IC50 values were found to be less than the values provided from HTS (41.36 µM,
and 22.57 µM in comparison to 85.3 µM and 60.2 µM for compounds D and H) , both IC50
values could not be reported with confidence due to the untraditional sigmoidal curves. The
variations between the IC50 curves are likely due to the scaling up of the reaction volume (47 µL
reactions for HTS compared to 150 µL reactions done in-house). The uncertainty of protein
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saturation suggests that the actual and more accurate IC50 value was likely higher due to the
skewed sigmoidal curves.
Overall, the ideal compound for WssI inhibition that was chosen from 12 carefully
assessed compounds was compound A. Compound A, commercially known as Tyrphostin AG
112 is an epidermal growth factor receptor (EGFR) inhibitor74. These receptors are significant in
oncology due to the activation of EGFR, which stimulates tumor growth and progression88,89.
Tyrphostin AG112 is classified as a tyrosine kinase inhibitor (by competitive inhibition of
phosphodiester bonds) and an antiproliferative compound74. The connection to WssI esterase
inhibition and tyrosine kinase inhibition is assumed to involve the inhibition of the cleavage of
the ester bonds. This suggests that Tyrphostin AG 112 may act as a competitive inhibitor to WssI
alike tyrosine kinase receptors, by blocking the hydrolysis of acetate from the acetyl donor in a
similar mechanism (unknown) when blocking autophosphorylation. The inability to cleave
acetate would eliminate the production of acetylated cellulose, presenting an unmodified and less
robust cellulose biofilm with decreased spreading and virulence; thereby less challenging to
combat.
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7. Summary
The aim of this research was to prove that WssI is an O-acetyltransferase proteininvolved in the acetylation of cellulose polymers within the exopolysaccharide matrix of
Achromobacter insuavis and Pseudomonas fluorescens biofilms. This hypothesis was tested by
optimizing the expression and purification of WssI (Objective 1), characterizing the function of
WssI (Objective 2), and outlining chemical compounds for further development of antiacetylation or antimicrobial agents by HTS (Objective 3). Due to the fact that WssI has never
been characterized before, there was a gap within the literature in regard to biochemical
information of proteins encoded by the wss operon. Thus, the biochemical characterization of the
putative acetyltransferase, WssI, has greatly improved our understanding of how the cellulose
polymer may be modified. Objective 1 was successfully achieved by optimizing the purification
of both WssI WT constructs, in addition to three mutant variants. This objective was achieved by
incorporating a secondary purification method, anion exchange, which yielded all WssI variants
with improved purity. Future studies, which would require high yields of WssI (i.e.,
crystallization), would require expression to be optimized further.
With working quantities of pure proteins, objective 2 was initiated by enzymatically
characterizing WssI in a series of standard esterase assays. The standard assay was used to
confirm esterase activity and transferase activity using three different acetyl donors (pNP-Ac, 4MUB-Ac and acetyl-CoA). Objective 2 was achieved as these findings were consistent with the
homolog, AlgJ, exhibiting weak polymer binding, thereby implying that WssI has esterase
activity and weak transferase activity in the absence of other proteins involved in acetyltransfer
(WssFGH) and under in vitro conditions. The function of WssI can be speculated to be similar to
AlgJ, acting as an intermediate protein between the MBOAT protein to provide the acetyl group
to the true acetyltransferase.
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A complete mutagenesis profile of the three catalytic residues of WssI was not
completed, however the knockouts of the serine residue for both AiWssI and PfWssI, and a
knockout of the histidine residue for AiWssI were assessed. Other knockout studies for the same
three conserved catalytic residues of homolog AlgJ and additional proposed O-acetyltransferase
protein WssF, revealed approximately 20% remaining activity of the proteins for all AlgJ
mutants and the histidine and aspartate mutants of WssF34,85. With some discrepancies between
the two studied acetyl donors, the serine mutants of WssI had approximately 80% remaining
activity, while the histidine gene mutant ranged from 30-50% remaining activity, providing it to
be catalytically important. Although the aspartate mutant was not tested through site directed
mutagenesis, the aspartate protease inhibitor pepstatin A was tested, but did not inhibit WssI.
Future studies are required to gain more information in regard to the active site and mechanism
of action of WssI.
High throughput screening was completed with primary screens, secondary screens, dose
response and fluorescence quenching testing to optimize a list of 12 compounds with the
assistance of Dr. Mark Nitz (University of Toronto). These 12 compounds were individually
tested for WssI inhibition in an attempt to determine an IC50. The findings from these assays
revealed 3 of the 12 compounds that displayed optimal inhibition of WssI in comparison to the
mutants. The three compounds had IC50 values of 28.4 µM, 41.36 µM and 22.57 µM for
compounds A, D and H, respectively. Compound A exhibited the optimal criteria for an IC50
curve with one of the lowest IC50 values for both the SPARC BioCentre and on-site. This
reproducibility provided confidence that compound A was an ideal inhibitor of WssI. The
commercial name of compound A is Tyrphostin AG112, which is classified as a tyrosine kinase
inhibitor. We hypothesize that Tyrphostin AG 112 acts as a competitive inhibitor to WssI alike
tyrosine kinase receptors, blocking the hydrolysis of acetate in a similar mechanism when

112

blocking autophosphorylation. The inhibition of acetate cleavage is predicted to still allow
cellulose synthesis and export for biofilm development, however the loss of the modification
would change the phenotype, fitness and overall integrity of the biofilm.
Although the information collected in this thesis does not clearly outline the exact
mechanism of action of WssI, we predict that the mechanism would function in a similar fashion
as the original predicted mechanism (Figure 8). We can confidently say that WssI has esterase
activity and the weak binding to a cellulose derivative. The transfer of an acetyl group onto
cellopentaose and cellohexaose by WssI using various donors was visualized by mass
spectrometry and proved acetyltransfer abilities of WssI. This thesis outlined novel biochemical
research implying that WssI is an important protein within the wss system, however the low
levels of activity suggests that WssI plays intermediary role involved in acetyltransfer in vivo.
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8. Integrative Nature of this Research
Bacteria are ubiquitously found on all surfaces in the environment and even within the
human body. In some cases, bacteria can congregate, interacting to produce copious amounts of
small molecules in a thick gel-like coating on surfaces referred to as a biofilm. Biofilms
produced by the Gram-negative emergent pathogens Pseudomonas fluorescens and
Achromobacter insuavis have been involved in contaminating fresh produce including sprouts,
lettuce, melons, tomatoes and spinach, as well as water sources and drainage systems6. Both
pathogens have also been found within/on the human body, such as the uterus, urinary tract, skin,
sinuses, lungs, eye, cerebrospinal fluid, bone and most commonly the blood56. These bacterial
biofilm infections, especially with Achromobacter, have also been found within the lung
mucosae of cystic fibrosis patients29,54-55, 59,60. The locations of these bacterial biofilms are
ubiquitous and pose challenges for the health care system and agricultural system that have also
translated into substantial economic losses. Therefore, this research is integrative not only in the
affected sectors such as health care and agriculture, but the overall impact of biofilm infections
has large implications for the economy, integrating the importance of this research into business
and government, later effecting the general public.
The formation of an acetylated cellulose biofilm is the topic of the research project. The
findings and future studies are important to develop a better understanding of the mechanism in
which this process occurs, with the long-term goal of identifying potential anti-biofilm agents or
techniques to effectively treat and prevent the persistence of organisms that form these biofilms.
This goal could not be met without the research of the Bcs, Alg, PatB and OatA systems, not
only for the homology structural and functional models, but due to the collaborative research as
the projects as a whole. This research integrates into the network of biofilm research, which is
much larger than the scope of this project. On a smaller scale the research done to improve
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knowledge of biofilms utilizes integrative techniques of biology, chemistry and biochemistry.
For example, the expression of protein within a microbial host and the purification of proteins
utilizing bioanalytical instruments were all required to produce protein for small-scale kinetic
assays, and very large-scale screens. Overall, the ubiquitous nature of harmful and advantageous
biofilms brings together multiple affected sectors, for the purpose of researching such biofilms to
find a solution, which ultimately could not be done without collaboration and the integration of
scientific techniques.
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Appendix
Table 11: Extinction Coefficient Values of pNP at pH 5.5-9.25.
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Figure 37: Residual Activity Trends of AiWssIH211A, AiWssIS309A and PfWssIS304A Esterase and
Transferase Reactions with pNP-Ac as Acetyl Donor.
Assays were performed in trials of 4 in 50 mM sodium phosphate buffer (pH 7), 1 mM
oligosaccharide, 3 µM WssI and 6 mM pNP-Ac. Panel A) Esterase and Transferase Remaining
activity of AiWssI WT, AiWssIH211A and AiWssIS309A; Panel B) Esterase and Transferase
Remaining activity of PfWssI WT, PfWssIS304A. Residual activity was calculated with reference
to the WssI wild-type esterase and transferase activity. *p < 0.05 mutants and therefore
statistically significant.
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Figure 38: Residual Activity Trends of AiWssIH211A, AiWssIS309A and PfWssIS304A Esterase and
Transferase Reactions with 4-MUB-Ac as Acetyl Donor.
Assays were performed in trials of 4 in 50 mM sodium phosphate buffer (pH 7), 1 mM
oligosaccharide, 3 µM WssI and 0.5 mM 4-MUB-Ac. Panel A) Esterase and Transferase
Remaining activity of AiWssI WT, AiWssIH211A and AiWssIS309A; Panel B) Esterase and
Transferase Remaining activity of PfWssI WT, PfWssIS304A. Residual activity was calculated
with reference to the WssI wild-type esterase and transferase activity. *p < 0.05 mutants and
therefore statistically significant.
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Figure 39: Relative Band Intensities indicating PfWssI and Avicel Binding with Increasing
Concentration of Avicel.
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PfWssI/1-374 MPAPTAPTPP SDLAVRTSPL AAWVLVPFLA AGLLSCVWLM VKGPISYVPA
AlgJ/79-356 ---------- ---------- ---------- ---------- ---------AlgX/41-450 ---------- ---------- ---------- ---------- ---------PfWssI/1-374 KVDSDMLLHG DLTHRFAKEL AKAPMAIQAA NLERGGSWLA FGDTGPRVRP
AlgJ/79-356 ---------- ---------- ---------- ---------- -----PGVVL
AlgX/41-450 ---------G NLCPA----- -----A--AY DSRYNTKYLG F---FTHLVQ
PfWssI/1-374 GCPGWLFISD E-LRINRHAE ANAQTKAQAV IDLQKQLGQK GIDLQVVVVP
AlgJ/79-356 GRDQWLFSDE E-FKPTAGAE QLMQENLALI RGVRDTLQQH GSQLVLAIVP
AlgX/41-450 AQDDWLFRTT YDLRTDFGT- --SAEGWREL RALRDELKRK GIELVVVYQP
PfWssI/1-374 DKSRIAAAQR CGLYRPA--- VLDNR-VRDW TAMLQAAGVS ALDLTETL-AlgJ/79-356 AKARVYTE-Y LGKERPA--- SLHDDLYNQF HAQARQANVF APDLMAPMEQ
AlgX/41-450 TRGLVNREKL SPAEKAGFDY ELAKKNYLAT IARFRQAGIW TPDFSPLFDPfWssI/1-374 KPLGAEAYLR TDTHWSEIGS NAGAKAVAQR TQQR-GIKAT PEQTFDITQA
AlgJ/79-356 AKARGQVFLR TDTHWTPMGA EVAAQALAEA VSRQ-SLLNG DPQAFITEAG
AlgX/41-450 EKEEHAYYFK GDHHWTPHGA RRSAKIVAET LKQVPGFEEI PKKQFESKRV
PfWssI/1-374 PLAVRPGDLV RLAGLDWLPP TLQPPGESVA ASTTHETGGA TSNADDLFGD
AlgJ/79-356 NTAPYKGDLT NFLPDPLFSN LL-PAPDNLQ KRT------- -------TRP
AlgX/41-450 GLLSKLGTFH KAA------- -AQLCGNSYA T--------- QYVDRFETEP
PfWssI/1-374 AGLPNVALIG TSFSRN--SN FVGFLQKALN APVGNFSKDG GEFSGAAKAY
AlgJ/79-356 VDQIPVALV G TSYSANPHWN FLGALQQALR SDVANYAEDG HGPLLPMLKY
AlgX/41-450 VGNPQIALV G TSNS-GPAYN FAGFLEEFSG ADILNNAVSG GGFDSSLLAY
PfWssI/1-374 FDSPAFKQTP PKLLIWEIPE RDLQTPYDVI TIGQ------ ---------AlgJ/79-356 LQSDAFKNAA PQVVVWEFPE RYLPMKNDLS SFDPQWIAQL KNSR-----AlgX/41-450 MTSEEFHKNP PKILIWEFAT HYDMAQKSFY R---QAMPLV DNGCSGRKTV
PfWssI/1-374 ---------- ---------- ---------- ---------- ---------AlgJ/79-356 ---------- ---------- ---------- ---------- ---------AlgX/41-450 LSRKVKLRQG RNEVLLNSAA LPIRSGSYVA DVTYSDPSVH ELKNTIWYMN
PfWssI/1-374 ---------- ---------- ---------- ---------- ---------AlgJ/79-356 ---------- ---------- ---------- ---------- ---------AlgX/41-450 GRREQLKIEQ SKAVDTGGRY VFQLRNDSDW ADQQFLSLEI EAPDMPQGLE
PfWssI/1-374 --------AlgJ/79-356 --------AlgX/41-450 VQASICQAA

Figure 40: Full Sequence Alignment of PfWssI, AlgJ and AlgX.
Conserved Asp (D), His (H) and Ser (S) residues are highlighted in yellow. Data obtained from
Clustal Omega.
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